Clinical News

Non-Hodgkins Lymphoma News

Sorry, there are no news articles available for Non-Hodgkins Lymphoma.

Latest Non-Hodgkins Lymphoma News By Stage

Sorry, there are no articles available for this cancer stage.

More A

Acute Lymphoblastic Leukemia

Iclusig Approved for CML and ALL (January 4, 2013)

The U.S. Food and Drug Administration (FDA) has approved Iclusig™ (ponatinib) to treat adults with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases. Chronic... Continue Reading

Blinatumomab Prolongs Survival in Relapsed/Refractory Adult ALL (December 14, 2012)

Blinatumomab induces high complete remission rates and prolongs survival in adult patients with relapsed/refractory B-precursor acute lymphoblastic lymphoma (ALL), according to the results of a study presented at the 54th Annual Meeting of the American... Continue Reading

Marqibo Approved for Treatment of Philadelphia-Negative ALL (August 17, 2012)

The U.S. Food and Drug Administration (FDA) has approved Marqibo® (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL) whose leukemia has returned or progressed following... Continue Reading

One Subset of Childhood Acute Lymphoblastic Leukemia is Best Treated with Chemotherapy (April 20, 2012)

A subset of young patients with acute lymphoblastic leukemia (ALL) who fail to achieve remission after the initial weeks of intense chemotherapy known as induction therapy appear to have better outcomes with additional chemotherapy rather than bone marrow... Continue Reading

Survival Continues to Improve Among Children and Adolescents with ALL (March 15, 2012)

Between 1990 and 2005, five-year survival for children and adolescents with acute lymphoblastic leukemia (ALL) increased from 83.7 percent to 90.4 percent. These results were published in the Journal of Clinical Oncology. ALL—a fast-growing cancer of... Continue Reading

More Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

CPX-351 Highly Active in Older Patients with AML (January 18, 2013)

CPX-351 is highly active in all patient subgroups and produced the greatest benefits in response rate and reduction in 60-day mortality compared to standard therapy in older patients with secondary acute myeloid leukemia and adverse cytogenetics, according... Continue Reading

Combination of Revlimid and Vidaza Beneficial in Untreated Elderly Patients with AML (January 14, 2013)

The sequential combination of Vidaza® (azacitidine) and Revlimid® (lenalidomide) shows evidence of clinical activity as initial therapy for older patients with acute myeloid leukemia, according to the results of a phase II study presented at the 54th... Continue Reading

Quizartinib Shows Promise in Treatment-Resistant AML (December 19, 2012)

The targeted agent quizartinib showed promise in the treatment of a subset of patients with treatment-resistant acute myeloid leukemia (AML), according to the results of a study presented at the 54th Annual Meeting of the American Society of Hematology... Continue Reading

Low Doses of Mylotarg May Improve Survival in Older Patients with Acute Myeloid Leukemia (May 2, 2012)

Patients age 50-70 with previously untreated acute myeloid leukemia (AML) who are treated with Mylotarg® (gemtuzumab ozogamicin) plus standard chemotherapy appear to live longer than those who are treated with standard chemotherapy alone, according to... Continue Reading

Gene Mutations Linked with AML Outcome (March 28, 2012)

Among patients with acute myeloid leukemia (AML), those with certain genetic changes may benefit from high-dose induction chemotherapy. These results were published in the New England Journal of Medicine. Acute myeloid leukemia is a cancer of the bone... Continue Reading

More Acute Myeloid Leukemia

Acute Promyelocytic Leukemia

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

A study of “chemo brain”—the foggy thinking and forgetfulness that patients may experience after chemotherapy—suggests that the condition improves substantially over time for a majority of patients. For some patients, however, symptoms may persist... Continue Reading

More Acute Promyelocytic Leukemia

Adjuvant (I-III, A-C) Colon Cancer

Second Large Study Confirms Oncotype DX Can Predict Recurrence in Stage 2 Colon Cancer (April 22, 2013)

Results from the large CALGB 9581 clinical validation study of the Oncotype DX® colon cancer test confirm that Recurrence Score® (RS) results improve the ability to differentiate high recurrence risk disease from low recurrence risk disease, beyond... Continue Reading

Oncotype DX in Colon Cancer May Reduce Medical Costs and Improve Patient Wellbeing (February 20, 2013)

The results of two studies evaluating Oncotype DX were presented at the 2013 Gastrointestinal Cancers Symposium in San Francisco and the data indicated that the colon cancer test may reduce medical costs, improve patient wellbeing, and change treatment... Continue Reading

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)

Daily aspirin use improves survival among patients with mutated-PIK3CA colorectal cancer, according to the results of a study published in the New England Journal of Medicine. Colorectal cancer remains the second leading cause of cancer-related death... Continue Reading

Oncotype DX Predicts Risk of Colon Cancer Recurrence (October 2, 2012)

Among patients with Stage II or Stage III colon cancer, the Oncotype DX colon cancer test provides information about risk of cancer recurrence and overall survival, and may help guide treatment decisions. These results were presented at the European Society... Continue Reading

Adjuvant Therapy May Offer Survival Benefit in Older Patients with Colorectal Cancer (September 11, 2012)

Adjuvant chemotherapy appears to offer a survival benefit to patients aged 75 years or older who have surgically resected colorectal cancer, according to the results of a study published in the Journal of Clinical Oncology. Colorectal cancer is the second... Continue Reading

More Adjuvant (I-III, A-C) Colon Cancer

Adult Acute Lymphoblastic Leukemia

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

More Adult Acute Lymphoblastic Leukemia

Advanced Stage Hodgkin's Lymphoma

Lymphoma During Pregnancy Can Have Good Outcomes (March 14, 2012)

Among women who are diagnosed with lymphoma during pregnancy, the outcomes for both mother and baby are often good. This was true for women who began lymphoma treatment during the second or third trimester of pregnancy, as well as women who deferred treatment... Continue Reading

Similar Overall Survival with ABVD and BEACOPP for Advanced Hodgkin’s Lymphoma (July 25, 2011)

Although the BEACOPP chemotherapy regimen produces better initial tumor control than the commonly used and less toxic ABVD regimen, the two regimens produce similar overall survival among patients with advanced Hodgkin’s lymphoma. These results were... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

Hodgkin’s Survivors at Increased Risk of Stroke (June 24, 2009)

Hodgkin’s Survivors at Increased Risk of Stroke Patients who have been treated with radiation therapy for Hodgkin’s lymphoma have an elevated risk of stroke. These results were published in the Journal of the National Cancer Institute. Hodgkin’s... Continue Reading

Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma (March 8, 2009)

Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma A recent study compared lymphocyte-predominant Hodgkin’s lymphoma (LPHL) and classical Hodgkin’s lymphoma (cHL) in order to define differences in patient characteristics... Continue Reading

More Advanced Stage Hodgkin's Lymphoma

Advisory Complementary Alternative Medicine

Combination of Herceptin® with Non–anthracycline-based Chemotherapy Appears to Be Effective (December 15, 2009)

Among women with early, HER2-positive breast cancer, the addition of Herceptin® (trastuzumab) to adjuvant chemotherapy reduces the risk of cancer recurrence and improves survival. Herceptin provides a benefit in combination with either anthracycline-... Continue Reading

More Advisory Complementary Alternative Medicine

Aggressive/Intermediate Grade Non-Hodgkin's Lymphoma

RIT Conditioning with Zevalin Prior to Autologous Transplantation Improves Overall Survival in Patients with DLCL (April 5, 2013)

Radioimmunotherapy conditioning with Zevalin® (ibritumomab tiuxetan) prior to autologous stem cell transplantation in patients with diffuse large cell lymphoma offers a similar relapse incidence to total body irradiation, but has lower toxicity and improved... Continue Reading

Treanda Plus Rituxan is Not Inferior to R-CHOP and R-CVP for advanced NHL (April 2, 2013)

The combination of Treanda® (bendamustine) and Rituxan® (rituximab) was found to be noninferior to the commonly used chemotherapy regimens R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) and R-CVP (rituximab plus cyclophosphamide,... Continue Reading

Zevalin Plus Nonmyeloablative Allogeneic Transplantation Effective in High-Risk B-Cell NHL (March 29, 2013)

The addition of Zevalin® (ibritumomab tiuxetan) to nonmyeloablative allogeneic transplantation (NMAT) is safe and produces early responses and prolonged disease control in high-risk patients with B-cell non-Hodgkin’s lymphoma, according to the results... Continue Reading

Zevalin Plus BEAM Chemotherapy Superior to BEAM Alone in Aggressive Lymphoma (March 22, 2013)

Standard-dose Zevalin® (ibritumomab tiuxetan) combined with BEAM high-dose chemotherapy is safe and possibly more effective than BEAM therapy alone as a conditioning regimen for autologous stem cell transplantation (ASCT), according to the results of... Continue Reading

Dose-Dense R-CHOP plus Zevalin Improves Response in Diffuse Large B-Cell Lymphoma (March 1, 2013)

Dose-dense R-CHOP followed by Zevalin® (ibritumomab tiuxetan) converts partial responses to complete responses and maintains durable responses in patients with untreated diffuse large B-cell lymphoma, according to the results of a study presented at... Continue Reading

More Aggressive/Intermediate Grade Non-Hodgkin's Lymphoma

All Cancer Types

Number of Cancer Survivors Expected to Reach 18 Million by 2022 (May 1, 2013)

As of January 2012, there were approximately 13.7 million cancer survivors in the United States and that number is expected to rise by 31 percent to 18 million by 2022, according to the second Annual Report on Cancer Survivorship in the United States published... Continue Reading

Heart Healthy Lifestyle Can Reduce Cancer Risk (April 19, 2013)

Following a heart-healthy lifestyle to reduce the risk for heart disease can also help prevent cancer, according to the results of a study published in Circulation. The American Heart Association designed their educational program My Life Check® in order... Continue Reading

Familial Cancer Risk Present in Both Young and Older Diagnosis (January 30, 2013)

Although early onset cancers tend to have a more pronounced hereditary component than cancers that develop at a later age, there is still an increased risk of some familial cancers even when a parent is diagnosed at an older age, according to the results... Continue Reading

Exercise Reduces Cancer-Related Fatigue (November 30, 2012)

Aerobic exercise can relieve the fatigue associated with cancer and its treatment, according to an updated systematic review published in The Cochrane Library. Fatigue is one of the most common side effects of cancer and its treatment. There are many... Continue Reading

Statins Linked to Lower Cancer Mortality (November 19, 2012)

Cancer patients who used statins (cholesterol-lowering drugs) prior to their cancer diagnosis have a 15 percent lower risk of dying from cancer, according to the results of a study published in then New England Journal of Medicine.[1] Statins are cholesterol-lowering... Continue Reading

More All Cancer Types

Allogeneic Stem Cell Transplant

Antiretroviral Drug May Prevent Graft-Versus-Host Disease (August 6, 2012)

The drug Selzentry® (maraviroc), which is typically used to treat HIV infection, may help prevent graft-versus-host disease (GVHD), a potentially lethal complication of stem cell transplants, according to the results of a study published in the New... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

Complementary Therapy for Children Undergoing Stem Cell Transplant (July 19, 2010)

Complementary therapies such as massage and humor therapy may not help children cope with the potential emotional distress associated with stem cell transplantation, according to findings recently reported in Cancer. Stem cell transplantation involves... Continue Reading

Statins May Reduce Acute Graft-versus-host Disease (March 8, 2009)

Statins May Reduce Acute Graft-versus-host Disease Researchers from Ohio State University have reported that statins may reduce the risk of developing acute graft-versus-host disease (GVHD) among patients who undergo allogeneic stem cell transplants.... Continue Reading

Stem Cell Transplant Procedures Vary Throughout the World (March 8, 2009)

Stem Cell Transplant Procedures Vary Throughout the World Stem cell transplant practices vary substantially among physicians treating adults and children with hematologic malignancies (cancers of the blood or bone marrow such as leukemias and lymphomas).... Continue Reading

More Allogeneic Stem Cell Transplant

Alphabetical Sort

Sorry, there are no articles available for this cancer stage.

More Alphabetical Sort

Alternative Medical Systems Complementary Alternative Medicine

Sorry, there are no articles available for this cancer stage.

More Alternative Medical Systems Complementary Alternative Medicine

Anal Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading

Anal Cancer Rates Appear to Be On the Rise in the U.S. (May 6, 2013)

The number of people in the United States with anal cancer has tripled since the 1970s, according to the results of a study published in the Journal of Clinical Oncology. Anal cancer is an uncommon type of cancer that occurs in the anal canal, the opening... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute. What’s more—cancer incidence... Continue Reading

Anal Cancer on the Rise in Men with HIV (October 15, 2012)

Nearly one-third of men with anal cancer have the human immunodeficiency virus (HIV), according to the results of a study published in the Journal of the National Cancer Institute. Anal cancer is an uncommon type of cancer that occurs in the anal canal,... Continue Reading

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according to the results of a study published in The Lancet... Continue Reading

More Anal Cancer

Autologous Stem Cell Transplant

Zevalin Plus BEAM Chemotherapy Superior to BEAM Alone in Aggressive Lymphoma (March 22, 2013)

Complementary Therapy for Children Undergoing Stem Cell Transplant (July 19, 2010)

Kepivance Reduces Toxicity of High-dose Therapy for Multiple Myeloma (March 24, 2010)

Among patients undergoing high-dose therapy and autologous stem cell transplantation for multiple myeloma, a three-day short course of Kepivance® (palifermin) reduces the toxicity of treatment. These results were published in the Annals of Oncology. Multiple... Continue Reading

Stem Cell Transplant Procedures Vary Throughout the World (March 8, 2009)

More Autologous Stem Cell Transplant

Sorry, there are no articles available for this cancer stage.

More B

Barrett's Esophagus Esophageal Cancer

Surgeon Volume Influences Outcomes in Esophageal Cancer (February 6, 2013)

Patients who undergo surgery for esophageal cancer have a much higher chance of long-term survival if the surgeon has performed the operation many times before, according to the results of a study published in the Journal of Clinical Oncology. The esophagus... Continue Reading

Barrett’s Esophagus May Carry Lower Risk of Esophageal Cancer Than Previously Reported (July 8, 2011)

Barrett’s esophagus—a condition characterized by abnormal cells in the lower part of the esophagus—may carry a lower risk of esophageal cancer than previously reported. These results were published in the Journal of the National Cancer Institute. The... Continue Reading

More Barrett's Esophagus Esophageal Cancer

Biologic-Orthomolecular Therapies Complementary Alternative Medicine

Sorry, there are no articles available for this cancer stage.

More Biologic-Orthomolecular Therapies Complementary Alternative Medicine

Biological Therapy

Sorry, there are no articles available for this cancer stage.

More Biological Therapy

Bladder Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Robotic Bladder Cancer Surgery Safe and Effective (January 24, 2013)

Robotic-assisted surgery for invasive bladder cancer is effective and results in less bleeding and shorter hospital stays when compared to the traditional open procedure, according to the results of a study published in the Journal of Urology. The bladder... Continue Reading

More Evidence that Diabetes Drugs Increase Risk of Bladder Cancer (August 22, 2012)

A popular class of diabetes drugs called thiazolidinediones (TZDs) increases the risk of bladder cancer, according to the results of a study published early online in the Journal of the National Cancer Institute. Bladder cancer is diagnosed in as many... Continue Reading

Diabetes Drugs May Increase Risk of Bladder Cancer (July 26, 2012)

A class of drugs called thiazolidinediones has been linked to an increased risk of bladder cancer among adults with type 2 diabetes, according to a study published early online in the Canadian Medical Association Journal. Bladder cancer is diagnosed... Continue Reading

More Bladder Cancer

Bone Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Xgeva Reduces Giant-cell Tumor of the Bone (October 2, 2012)

Xgeva® (denosumab) significantly reduced or eliminated tumor giant cells in patients with giant-cell tumor of the bone and also increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research. Giant cell... Continue Reading

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading

More Bone Cancer

Brain Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Early Resection of Low-Grade Gliomas Improves Survival (November 21, 2012)

Patients in Norway with low-grade gliomas who were treated with early surgical resection had better overall survival than those treated with biopsy and watchful waiting, according to the results of a study published in the Journal of the American Medical... Continue Reading

Repeated Surgeries Improve Survival in Glioblastoma (November 13, 2012)

Patients with recurrent glioblastoma who undergo multiple surgeries to remove tumors may survive longer than those who undergo only one surgery, according to the results of a study published in the Journal of Neurosurgery. Glioblastoma mutiforme (GBM)... Continue Reading

Chemotherapy Plus Radiation Improves Survival for Anaplastic Oligodendroglioma (October 29, 2012)

Some patients with anaplastic oligodendroglioma live substantially longer if they are treated with a combination of chemotherapy and radiation instead of radiation alone, according to the long-term results of two studies published in the Journal of Clinical... Continue Reading

More Brain Cancer

Breast Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

False-Positive Mammograms Leave a Long-Term Psychological Impact (May 3, 2013)

A false-positive mammogram can cause long-term psychosocial harm, according to the results of a study published in the Annals of Family Medicine—in fact, three years later, women still suffer the psychological after-effects of the scare. A mammogram... Continue Reading

Combined Hormone Replacement Therapy Linked to Increased Risk of Breast Cancer (April 26, 2013)

The use of combined hormone replacement therapy with estrogen plus progestin among postmenopausal women was associated with an increased risk of breast cancer, according to the results of a long-term analysis published in the Journal of the National Cancer... Continue Reading

Biennial Mammography is Appropriate for Women Ages 50-74 (April 16, 2013)

Women ages 50 to 74 who undergo mammography screening every other year have a similar risk of advanced-stage disease and a lower cumulative risk of false-positive results than those who get mammograms every year, according to the results of a study published... Continue Reading

Study Explores Breast Cancer Prognosis By Race (April 11, 2013)

Breast cancer prognosis may be worse among black women than among white women regardless of the subtype of breast cancer. These results were presented at the 2013 annual meeting of the American Association for Cancer Research (AACR). It’s long been... Continue Reading

More Breast Cancer

Sorry, there are no articles available for this cancer stage.

More C

Cancer Dictionary

Sorry, there are no articles available for this cancer stage.

More Cancer Dictionary

Carcinoma In Situ Breast cancer

Breast Brachytherapy May Result in More Complications (October 31, 2012)

Brachytherapy is tied to more wound and skin complications than the standard radiation technique, according to the results of a study published in the Journal of Clinical Oncology. For women with early-stage breast cancer who are treated with breast-conserving... Continue Reading

Physical Activity Linked to Reduced Mortality in Breast and Colon Cancer (May 22, 2012)

Physical activity is associated with reduced mortality in patients with breast and colon cancer, according to a study published in the Journal of the National Cancer Institute.[1] So far, there is insufficient evidence to draw the same conclusion with... Continue Reading

Tamoxifen Benefits Subset of Women with DCIS (March 9, 2012)

Among women who have estrogen receptor-positive ductal carcinoma in situ (DCIS) of the breast, adjuvant (post-surgery) treatment with tamoxifen may reduce the risk of subsequent breast cancer. These results were published in the Journal of Clinical Oncology. DCIS... Continue Reading

Oncotype DX DCIS Score Predicts Recurrence Risk for Women with DCIS (December 8, 2011)

A DCIS Score generated by the Oncotype DX breast cancer test provides information about how likely it is that breast ductal carcinoma in situ (DCIS) will recur. This may help guide decisions about whether women with DCIS need radiation therapy after breast-conserving... Continue Reading

Study Evaluates Predictors of DCIS Outcomes (January 11, 2011)

Choice of treatment, choice of surgeon, and surgical margin (a measure of whether the cancer was completely removed) all appear to affect the risk of disease recurrence among women with ductal carcinoma in situ (DCIS) of the breast. These findings were... Continue Reading

More Carcinoma In Situ Breast cancer

Cervical Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

HPV Test Appropriate After Indeterminate Pap Test (April 29, 2013)

Women who have an indeterminate Pap smear should undergo human papillomavirus (HPV) testing rather than another Pap smear, according to the results of Cochrane Review. Cancer screening refers to the use of tests to detect cancer in individuals who do... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Gardasil is Safe, According to Large Study (October 12, 2012)

The HPV vaccine Gardasil® (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) was found to be safe, according to the results of a large safety study published in the Archives of Pediatrics & Adolescent Medicine. The study... Continue Reading

HPV Testing Can Predict Risk of Cervical Cancer for Up to 18 Years (August 8, 2012)

A test for the human papillomavirus (HPV) provides information about a woman’s long-term risk of cervical precancers, according to the results of a study published early online in the Journal of Clinical Oncology. Each year in the United States, there... Continue Reading

More Cervical Cancer

Chemotherapy

Sorry, there are no articles available for this cancer stage.

More Chemotherapy

Childhood Acute Lymphoblastic Leukemia

One Subset of Childhood Acute Lymphoblastic Leukemia is Best Treated with Chemotherapy (April 20, 2012)

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

More Childhood Acute Lymphoblastic Leukemia

Chronic Lymphoblastic Leukemia

Lymphoma Patients and Transplant Recipients at Higher Risk of Melanoma (October 11, 2012)

Individuals with lymphoma or those who have undergone organ transplants are far more likely than the average person to develop—and die from—melanoma, according to the results of a review published in Mayo Clinic Proceedings. Melanoma is a potentially... Continue Reading

Combination of Campath and Fludarabine Provides Benefit in CLL (February 16, 2012)

Among people with previously treated, relapsed or refractory chronic lymphocytic leukemia (CLL), treatment with a combination of Campath® (alemtuzumab) and fludarabine results in better outcomes than treatment with fludarabine alone. These results were... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

Survivors of Some Childhood Cancers May Face Cognitive Impairment (May 18, 2010)

Survivors of non-central nervous system (CNS) childhood cancers reported a statistically and clinically significantly higher rate of neurocognitive impairment than their cancer-free siblings, according to the results of a study published in the Journal... Continue Reading

Arzerra, Fludara, and Cytoxan Promising for Previously Untreated CLL (February 1, 2010)

The combination of Arzerra™ (ofatumumab), Fludara® (fludarabine), and Cytoxan® (cyclophosphamide) shows promising effectiveness in the initial treatment of chronic lymphocytic leukemia (CLL). These results were presented at the 2009 annual meeting... Continue Reading

More Chronic Lymphoblastic Leukemia

Chronic Lymphocytic Leukemia

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

Fludara plus Rituxan Extends Survival in CLL (April 6, 2010)

Patients with untreated chronic lymphocytic leukemia experienced prolonged survival when treated with Fludara® (fludarabine) plus Rituxan® (rituximab) (delivered either concurrently or sequentially), according to the results of a study presented... Continue Reading

Rituxan Approved for Chronic Lymphocytic Leukemia (February 24, 2010)

The U.S. Food and Drug Administration (FDA) has expanded the approval of Rituxan® (rituximab) to include the treatment of certain patients with chronic lymphocytic leukemia. Chronic lymphocytic leukemia (CLL) is the most common adult leukemia with... Continue Reading

Arzerra™ Approved for Refractory Chronic Lymphocytic Leukemia (October 28, 2009)

The targeted therapy Arzerra™ (ofatumumab) has been granted accelerated approval by the U.S. Food and Drug Administration for treatment of patients with chronic lymphocytic leukemia (CLL) that is refractory to Fludara® (fludarabine) and Campath® (alemtuzumab). Chronic... Continue Reading

Abnormal Cells Identified in Blood Years Before Diagnosis of CLL (March 9, 2009)

According to the results of a study published in the New England Journal of Medicine, chronic lymphocytic leukemia (CLL) appears to be preceded by a condition known as monoclonal B-cell lymphocytosis (MBL). Chronic lymphocytic leukemia is the most common... Continue Reading

More Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Iclusig Approved for CML and ALL (January 4, 2013)

Tasigna Superior to Gleevec for Philadelphia Chromosome-Positive CML (December 21, 2012)

Tasigna® (nilotinib) is superior to Gleevec® (imatinib) for the treatment of patients with Philadelphia chromosome-positive chronic myeloid leukemia (CML), according to the results of two studies presented at the 54th Annual Meeting of the American... Continue Reading

Synribo Approved for CML (November 8, 2012)

The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults. Each year in the United States, approximately... Continue Reading

Bosulif Approved for CML (September 26, 2012)

The U.S. Food and Drug Administration (FDA) has approved Bosulif® (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults. The drug is intended for patients with chronic, accelerated... Continue Reading

Ponatinib Produces High Response Rates in CML (August 13, 2012)

Ponatinib, an investigational targeted agent, appears to be significantly effective in treatment-refractory chronic myeloid leukemia (CML) and produces early and lasting responses, according to the preliminary results of a study presented at the 2012... Continue Reading

More Chronic Myeloid Leukemia

Colon Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Second Large Study Confirms Oncotype DX Can Predict Recurrence in Stage 2 Colon Cancer (April 22, 2013)

Combo Treatment Effective in Elderly Patients with Metastatic Colorectal Cancer (March 6, 2013)

Combination therapy with Avastin® (bevacizumab) and Xeloda® (capecitabine) may be an optimal first-line treatment for treatment-naïve older patients with metastatic colorectal cancer, according to the results of a study presented at the 2013 Gastrointestinal... Continue Reading

Neulasta Significantly Reduces Febrile Neutropenia Among Colorectal Cancer Patients Receiving Chemotherapy Plus Avasatin (February 25, 2013)

Neulasta® (pegfilgrastim) significantly reduced the incidence of grade 3/4 febrile neutropenia among patients with locally advanced or metastatic colorectal cancer who received chemotherapy with FOLFOX or FOLFIRI followed by Avastin® (bevacizumab),... Continue Reading

Oncotype DX in Colon Cancer May Reduce Medical Costs and Improve Patient Wellbeing (February 20, 2013)

More Colon Cancer

Complementary Alternative Medicine

High Prevalence of CAM Use Among Thyroid Cancer Patients (November 1, 2010)

Among patients with thyroid cancer, use of complementary and alternative medicine is common, with more than 80% reporting use. These results were presented at the 14th International Thyroid Congress. Complementary and alternative medicines are therapies... Continue Reading

Fish Oil Linked to Reduction in Breast Cancer Risk (July 9, 2010)

A recent study suggests that regular use of fish oil supplements may reduce the risk of breast cancer. These findings were published in the journal of Cancer Epidemiology, Biomarkers & Prevention.[1] Dietary supplements are a booming business—Americans... Continue Reading

Use of Complementary and Alternative Medicine Common in Pediatric Cancer Patients (April 9, 2010)

Pediatric cancer patients commonly use complementary and alternative medicine (CAM), according to a review article recently published in the journal Pediatrics.[1] The landscape of medicine has been dramatically changing over the past several decades.... Continue Reading

Women&Cancer Magazine Features Paula Zahn on Spring 2008 Cover (March 8, 2009)

Women&Cancer Magazine Features Paula Zahn on Spring 2008 Cover March 17, 2008 Press Contact: Diana Price dprice@omnihealthmedia.com (208) 727-2108, ext. 202 March 17, 2008-Zahn Appears on Women&Cancer cover, Spring 2008 News anchor... Continue Reading

More Complementary Alternative Medicine

Corticosteroid

Sorry, there are no articles available for this cancer stage.

More Corticosteroid

Sorry, there are no articles available for this cancer stage.

More D

Drug Dictionary

Sorry, there are no articles available for this cancer stage.

More Drug Dictionary

Sorry, there are no articles available for this cancer stage.

More E

Early Stage Hodgkin's Lymphoma

Children with Favorable-Risk Hodgkin’s Lymphoma May Benefit from Limited Radiation Therapy (July 6, 2012)

Children with favorable-risk Hodgkin’s lymphoma who achieve a complete early response to chemotherapy may not require radiation therapy or may undergo limited radiation therapy, according to the results of a study published in the Journal of the American... Continue Reading

Lymphoma During Pregnancy Can Have Good Outcomes (March 14, 2012)

Chemotherapy Alone Effective for Hodgkin’s Lymphoma (February 10, 2012)

Among patients with Stage IA or IIA nonbulky Hodgkin’s lymphoma, treatment with chemotherapy alone resulted in better overall survival than treatment that included radiation therapy. These results were published in the New England Journal of Medicine. Hodgkin’s... Continue Reading

Limited Therapy May Cure a Significant Fraction of Pediatric Patients with Early-Stage Hodgkin Lymphoma (June 13, 2011)

At the 2011 meeting of the American Society of Clinical Oncology, researchers involved in the Pediatric Oncology Study Group (POG) reported that selected pediatric patients with stage I and II Hodgkin lymphoma could be cured without alkylating agent chemotherapy... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

More Early Stage Hodgkin's Lymphoma

Early Stage I-II (A-B) Prostate Cancer

Genomic Test May Help Guide Prostate Cancer Treatment (May 13, 2013)

A new genetic test—the Oncotype DX® Prostate Cancer Test—measures the aggressiveness of prostate cancer and may help scores of men choose between immediate treatment or active surveillance. The test was shown to strongly predict aggressiveness of... Continue Reading

Surgery and Radiation for Prostate Cancer Produce Similar Functional Outcomes (February 27, 2013)

Men with localized prostate cancer experience declines in sexual, urinary, and bowel function over time, regardless of whether they choose surgery or radiation therapy, according to the results of a study published in the New England Journal of Medicine. Each... Continue Reading

No Difference in Toxicity Between Proton Therapy and IMRT for Prostate Cancer (January 28, 2013)

Proton therapy does not reduce toxicity compared with intensity-modulated radiation therapy (IMRT) in men with prostate cancer, according to the results of a study published in the Journal of the National Cancer Institute. Prostate cancer is the most... Continue Reading

Viagra Improves Sexual Function after Radiation for Prostate Cancer (November 15, 2012)

Viagra® (sildenafil citrate) administered before, during, and after radiation therapy improved overall sexual function in prostate cancer patients, according to the results of a study presented at the 54th annual meeting of the American Society for... Continue Reading

Intermittent and Continuous Hormone Therapy are Equally Effective in Prostate Cancer Treatment (September 18, 2012)

Hormone therapy given intermittently (with breaks) has proven to be as effective as hormone therapy given continuously in asymptomatic men with rising PSA levels after prostate cancer treatment, according to the results of a study published in the New... Continue Reading

More Early Stage I-II (A-B) Prostate Cancer

Esophageal Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Second-Line Docetaxel Improves Survival in Esophageal and Gastric Cancer (April 3, 2013)

Second-line treatment with docetaxel improves overall survival of patients with advanced esophageal and gastric cancer, according to the results of a study presented at the 2013 Gastrointestinal Cancers Symposium in San Francisco. The esophagus is a muscular... Continue Reading

Surgery Improves Survival in Esophageal Cancer (February 21, 2013)

Surgery after chemoradiotherapy—which is the standard of care in advanced esophageal cancer—increased overall and disease-free survival compared with chemoradiotherapy alone, according to the results of a study presented at the 2013 Gastrointestinal... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Surgeon Volume Influences Outcomes in Esophageal Cancer (February 6, 2013)

More Esophageal Cancer

Ewing's Sarcoma Overview

Shorter Chemotherapy Intervals Effective in Ewing Sarcoma (November 1, 2012)

In patients with localized Ewing sarcoma, chemotherapy administered every two weeks is more effective than chemotherapy administered every three weeks, with no increase in toxicity, according to the results of a study published in the Journal of Clinical... Continue Reading

Children with Ewing’s Sarcoma or Astrocytoma Most Likely to Experience Late Recurrence (February 19, 2010)

Late recurrence of childhood cancers appears to occur most often in Ewing’s sarcoma and astrocytoma, according to the results of a study published in the Journal of the National Cancer Institute. As cancer treatment has improved and evolved, the number... Continue Reading

Children with Ewing’s Sarcoma or Astrocytoma Most Likely to Experience Late Recurrence (February 19, 2010)

More Ewing's Sarcoma Overview

Extensive Lung Cancer - Small Cell

Xgeva Improves Survival Over Zometa in Advanced Lung Cancer (November 28, 2012)

Patients with advanced lung cancer experienced modest improvement in survival when they received bone-targeted therapy with Xgeva® (denosumab) instead of Zometa® (zoledronic acid), according to the results of a study published in the Journal of Thoracic... Continue Reading

Prophylactic Cranial Irradiation May Improve Survival in Small Cell Lung Cancer (June 14, 2011)

Radiation to the brain prior to detectable spread of cancer to the brain improved survival in patients with both early- and late-stage small cell lung cancer. These results were recently presented at the 2011 meeting of the American Society of Clinical... Continue Reading

Some Patients with Advanced Cancer Continue Screening (October 22, 2010)

A significant proportion of patients with advanced cancers continue to undergo cancer screening, even though screening is unlikely to benefit these patients. These findings were recently reported in the Journal of the American Medical Association. Cancer... Continue Reading

Depression May Persist With Metastatic Cancer (May 27, 2010)

A substantial number of patients with metastatic cancer may suffer from depression which tends to persist and grow more severe toward the end of life, according to the results of a study published early online in the Journal of Clinical Oncology.[1] While... Continue Reading

Most Survivors of Lung and Colorectal Cancer Keep Their Jobs (April 15, 2010)

Among people diagnosed with nonmetastatic lung or colorectal cancer, the majority return to work, according to a study recently published in Journal of Clinical Oncology. Those who do leave the workforce tend to have worse prognoses and lower socioeconomic... Continue Reading

More Extensive Lung Cancer - Small Cell

Sorry, there are no articles available for this cancer stage.

More F

Follicular Lymphoma

Fractionated Zevalin Effective First-Line Treatment for Advanced Follicular Lymphoma (February 8, 2013)

Fractionated radioimmunotherapy treatment with Zevalin® (ibritumomab tiuxetan) is an effective first-line treatment for advanced stage follicular lymphoma and delivers high response rates in patients with high tumor burden, according to the results of... Continue Reading

Zevalin Effective as First-Line Treatment for Advanced Follicular Lymphoma (February 1, 2013)

Radioimmunotherapy treatment with Zevalin® (ibritumomab tiuxetan) is safe and well tolerated and induces a high rate of clinical and molecular responses when given as first-line treatment to patients with advanced stage follicular lymphoma, according... Continue Reading

Zevalin Effective in Follicular NHL Refractory to Rituximab (January 24, 2013)

Radioimmunotherapy treatment with Zevalin® (ibritumomab tiuxetan) is effective in patients with non-Hodgkin’s lymphoma that is refractory to treatment with Rituxan® (rituximab), according to the results of a study published in the Journal of Clinical... Continue Reading

Consolidation with Zevalin Significantly Improves Progression-Free Survival in Advanced Follicular Lymphoma (January 10, 2013)

Consolidation therapy with Zevalin® (ibritumomab tiuxetan) significantly prolongs progression-free survival and leads to high conversion rates from partial response to complete response in patients with advanced follicular lymphoma, according to the... Continue Reading

Lymphoma During Pregnancy Can Have Good Outcomes (March 14, 2012)

More Follicular Lymphoma

Sorry, there are no articles available for this cancer stage.

More G

Gastric Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Second-Line Docetaxel Improves Survival in Esophageal and Gastric Cancer (April 3, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Adjuvant Radiochemotherapy Demonstrates Benefit in Gastric Cancer (September 25, 2012)

Adjuvant radiochemotherapy provides strong and persistent benefit in patients who have undergone curative gastric resection, according to the long-term results of a study published in the Journal of Clinical Oncology.[1] Gastric cancer refers to cancer... Continue Reading

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

More Gastric Cancer

Gene Therapy

New Substances Added to List of Cancer-Causing Agents (June 21, 2011)

In the most recent version of the National Toxicology Program’s Report on Carcinogens, two new substances have been classified as “known human carcinogens” and six others have been classified as “reasonably anticipated to be human carcinogens.” The... Continue Reading

More Gene Therapy

General

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Number of Cancer Survivors Expected to Reach 18 Million by 2022 (May 1, 2013)

Heart Healthy Lifestyle Can Reduce Cancer Risk (April 19, 2013)

Mutation in Immortality Gene Linked to Brain and Other Tumors (April 17, 2013)

Newly identified mutations in a gene that makes cells immortal—the TERT promoter gene—appear to play a role in several types of cancer, including three of the most common types of brain tumors, according to the results of a study published in the... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

More General

General Bone Cancer

Xgeva Reduces Giant-cell Tumor of the Bone (October 2, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Xgeva Delays Onset of Bone Metastases (September 27, 2011)

Among men with prostate cancer that has stopped responding to hormonal therapy, the bone drug Xgeva™ (denosumab) delayed the spread of cancer to the bones. These results were presented at the 2011 European Multidisciplinary Cancer Conference. Androgen... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s important to update this information periodically... Continue Reading

Denosumab Active Against Giant Cell Tumor of Bone (February 11, 2010)

In a Phase II clinical trial, denosumab produced high rates of tumor response among patients with recurrent or unresectable giant cell tumors of bone. These results were published in Lancet Oncology. Denosumab is an investigational drug that targets... Continue Reading

More General Bone Cancer

General Brain Cancer

Early Resection of Low-Grade Gliomas Improves Survival (November 21, 2012)

Repeated Surgeries Improve Survival in Glioblastoma (November 13, 2012)

Chemotherapy Plus Radiation Improves Survival for Anaplastic Oligodendroglioma (October 29, 2012)

Temodar and Hypofractionated Radiotherapy Appropriate for Elderly Patients with Glioblastoma (August 21, 2012)

Both Temodar® (temozolomide) and hypofractionated radiotherapy should be considered as standard treatment options in elderly patients with glioblastoma, according to the results of a study published in the Lancet Oncology. Glioblastoma multiforme (GBM)... Continue Reading

Childhood CT Scans Linked to Leukemia and Brain Cancer Later in Life (June 20, 2012)

Children and young adults who undergo multiple computed tomography (CT) scans have an increased risk of leukemia and brain tumors in the decade following their first scan, according to the results of a study published in The Lancet. CT scans are a common... Continue Reading

More General Brain Cancer

General Complementary Alternative Medicine

Sorry, there are no articles available for this cancer stage.

More General Complementary Alternative Medicine

General Gene Therapy

Sorry, there are no articles available for this cancer stage.

More General Gene Therapy

General Head and Neck Cancer

Doxepin Reduces Mouth Pain from Radiation for Head and Neck Cancer (November 14, 2012)

The tricyclic antidepressant doxepin reduces oral mucositis in patients who receive radiation for head and neck cancer, according to the results of a study presented at the 54th annual meeting of the American Society for Radiation Oncology in Boston,... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Combined Treatment Provides Benefit for Nasopharyngeal Cancer (February 22, 2012)

Among patients with Stage II nasopharyngeal cancer (a type of head and neck cancer), adding chemotherapy to radiation therapy resulted in better survival than radiation therapy alone. These results were published in the Journal of the National Cancer... Continue Reading

Erbitux Approved for New Use in Head and Neck Cancer (November 18, 2011)

The US Food and Drug Administration has expanded the approval of Erbitux® (cetuximab) to include the initial treatment, in combination with platinum-based chemotherapy, of selected patients with recurrent or metastatic squamous cell head and neck cancer. Head... Continue Reading

HPV Vaccine Recommended for Boys (November 1, 2011)

The Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention (CDC) has recommended that boys be vaccinated against human papillomavirus (HPV). Human papillomaviruses (HPV) consist of more than 100 different viruses.... Continue Reading

More General Head and Neck Cancer

General HIV Related Cancers

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Stay on Top of Your Family History of Cancer (July 15, 2011)

Cancer Burden Has Changed for People with HIV/AIDS (April 14, 2011)

Among people living with AIDS in the United States, the frequency of AIDS-defining cancers such as Kaposi sarcoma decreased markedly between 1991 and 2005; the frequency of other types of cancer, however, increased three-fold. These results were published... Continue Reading

Study Evaluates Impact of Highly Active Antiretroviral Therapy (HAART) on Cancer Risk in HIV-infected Men (August 10, 2010)

Researchers reported that men infected with human immunodeficiency virus (HIV) are still at an increased risk of lymphoma, Kaposi’s sarcoma (KS), and anal cancer despite the introduction of highly active antiretroviral therapy (HAART). These findings... Continue Reading

More General HIV Related Cancers

General Lung Cancer

Screening Could Reduce Lung Cancer Mortality (April 24, 2013)

Screening for lung cancer with low-dose computed tomography (LDCT) in all screening-eligible current and former smokers could potentially avert approximately 12,000 lung cancer deaths each year in the United States, according to the results of a study... Continue Reading

Xgeva Improves Survival Over Zometa in Advanced Lung Cancer (November 28, 2012)

Female Lung Cancer Deaths on the Rise in Some Areas (July 3, 2012)

Lung cancer deaths are on the rise among young and middle-aged white women, mainly in the South and the Midwest, according to a study published in the Journal of Clinical Oncology. Lung cancer remains the leading cause of cancer death among both men and... Continue Reading

Diesel Exhaust Linked to Lung Cancer (June 26, 2012)

Diesel exhaust is associated with an increased risk of lung cancer, according to a press release issued by the World Health Organization (WHO).[1] The announcement came after a group of international experts gathered for a weeklong meeting to review the... Continue Reading

New Lung Cancer Screening Guidelines (May 25, 2012)

New lung cancer screening guidelines recommend annual CT scans only for a select group of people—those aged 55 to 74 who are current or former smokers. The guidelines are the result of a systematic review by an expert panel from several medical groups... Continue Reading

More General Lung Cancer

General Malignant Mesothelioma

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Stay on Top of Your Family History of Cancer (July 15, 2011)

MVP Does Not Provide Benefit in Mesothelioma Patients (May 21, 2008)

MVP Does Not Provide Benefit in Mesothelioma Patients The chemotherapy agent Navelbine® (vinorelbine) may improve outcomes for patients with malignant pleural mesothelioma. However, the combination chemotherapy regimen referred to as MVP (mitoxantrone,... Continue Reading

Minimally Invasive Endoscopic Procedure Shows Promise for Detecting Lung Cancer (February 8, 2008)

Minimally Invasive Endoscopic Procedure Shows Promise for Detecting Lung Cancer Use of a minimally invasive technique called endoscopy to detect lung cancer may be more effective than more complicated and invasive standard procedures. These findings were... Continue Reading

More General Malignant Mesothelioma

General Myelodysplastic Syndrome

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Stay on Top of Your Family History of Cancer (July 15, 2011)

Regular Use of Acetaminophen May Increase Risk of Blood Cancers (May 13, 2011)

Long-term, regular use of acetaminophen (Tylenol®) may increase the risk of leukemia and lymphoma. These results were published in the Journal of Clinical Oncology. Some studies have suggested that use of aspirin and other nonsteroidal anti-inflammatory... Continue Reading

Vidaza® Improves Survival in Higher-risk Myelodysplastic Syndromes (March 6, 2009)

According to the results of a Phase III clinical trial, treatment with Vidaza® (azacitidine) results in better survival than conventional care among patients with higher-risk myelodysplastic syndromes (MDS). These results were published in Lancet Oncology. Myelodysplastic... Continue Reading

The American Society of Clinical Oncology 2008: Highlights of Treatment of Hematological Malignancies (January 30, 2009)

The American Society of Clinical Oncology 2008: Highlights of Treatment of Hematological Malignancies The 2008 annual meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, Illinois, again revealed advances in the treatment of... Continue Reading

More General Myelodysplastic Syndrome

General Neuroblastoma

Targeted Agent Xalkori May Benefit Children with Anaplastic Lymphoma (May 23, 2012)

The targeted agent Xalkori® (crizotinib) appears to drastically reduce the size of tumors in children with refractory anaplastic large cell lymphoma, according to the results of a phase I study that will be presented at the annual meeting of the American... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Stay on Top of Your Family History of Cancer (July 15, 2011)

Improved Survival with Busulphan-Melphalan Chemotherapy in Pediatric Neuroblastoma (June 8, 2011)

Treatment with high doses of the chemotherapy combination including busulphan and melphalan significantly improves survival and reduces cancer progression among pediatric patients with high-risk neuroblastoma. These results were presented at a plenary... Continue Reading

Reduced Chemotherapy Regimen May Be Effective in Neuroblastoma (November 10, 2010)

According to results of a Phase III clinical trial, patients with intermediate-risk neuroblastoma may be effectively treated with reduced doses of chemotherapy given over a shorter period. These findings were published in the New England Journal of Medicine. Neuroblastoma... Continue Reading

More General Neuroblastoma

General Renal Cancer

New Treatment Options for Advanced Renal Cell Carcinoma (October 8, 2012)

The results from three phase III trials shed new light on treatment options for patients with advanced renal cell carcinoma. The studies were presented at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. More than 58,000... Continue Reading

PD-1 Targeted Immune Therapy Shows Promising Activity (June 11, 2012)

The investigational drug BMS-936558 caused tumor shrinkage in nearly 25 percent of patients with advanced melanoma, kidney cancer and non-small cell lung cancer (NSCLC), according to the results of a phase I study presented at the 2012 annual meeting... Continue Reading

Partial Nephrectomy is Associated with Improved Survival in Early Stage Kidney Cancer (April 27, 2012)

Patients with early stage kidney cancer who had only the tumor removed experienced better survival rates than those who had the entire kidney removed, according to the results of a study published in the Journal of the American Medical Association.[1] Nearly... Continue Reading

Tivozanib Promising for Metastatic Renal Cell Carcinoma (April 23, 2012)

Tivozanib (AV-951) was well tolerated and improved median progression-free survival (PFS) in some patients with advanced renal cell carcinoma (RCC), according to the results of a phase II study published in the Journal of Clinical Oncology. More than... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

More General Renal Cancer

General Retinoblastoma

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Lynch Syndrome Also Linked with Breast and Pancreatic Cancer (February 17, 2012)

A study of families with Lynch Syndrome has expanded the list of cancers related to the condition: carriers of a Lynch Syndrome gene mutation also appear to have an increased risk of breast cancer and pancreatic cancer. These results were published in... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

Retinoblastoma Survivors Face Risk of Second Cancers (March 8, 2009)

Retinoblastoma Survivors Face Risk of Second Cancers A study that followed retinoblastoma survivors for up to 61 years reported a high risk of second cancers among survivors of hereditary retinoblastoma. These results were published in the Journal of... Continue Reading

Chemotherapy for Retinoblastoma Delivered Directly into Eye May Save Eye (March 8, 2009)

Chemotherapy for Retinoblastoma Delivered Directly into Eye May Save Eye Chemotherapy delivered directly into the artery of the eye may save the eyeball in children with retinoblastoma. These results were recently published in an early online publication... Continue Reading

More General Retinoblastoma

General Sarcoma

Regorafenib May Expand GIST Treatment Options (June 13, 2012)

Among patients with gastrointestinal stromal tumors (GIST) that worsen in spite of standard treatment, the investigational drug regorafenib delays cancer progression. These results—from a Phase III clinical trial—were presented at the 2012 Annual... Continue Reading

Votrient Approved for the Treatment of Sarcoma (May 7, 2012)

The U.S. Food and Drug Administration (FDA) has approved Votrient® (pazopanib) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy. It is the first new drug in decades to treat this type of cancer. Soft... Continue Reading

Longer Treatment with Gleevec Effective Against Gastrointestinal Stromal Tumors (GIST) (April 9, 2012)

In a Phase III clinical trial, three years of adjuvant (post-surgery) treatment with Gleevec® (imatinib) resulted in better survival than one year of adjuvant treatment among patients with high-risk gastrointestinal stromal tumors (GIST). These results... Continue Reading

Genetic Change Linked with Rhabdomyosarcoma Survival (April 4, 2012)

For children with rhabdomyosarcoma, a test for a specific genetic change could eventually improve risk estimates and treatment decisions. These results were published in the Journal of Clinical Oncology. Rhabdomyosarcoma is a soft-tissue cancer that arises... Continue Reading

FDA Updates Use of Gleevec for Gastrointestinal Stromal Tumors (February 29, 2012)

In changes approved by the US Food and Drug Administration (FDA), the prescribing information for Gleevec® (imatinib) now notes that three years of adjuvant (post-surgery) treatment results in better survival than one year of adjuvant treatment among... Continue Reading

More General Sarcoma

General Skin Cancer

Coffee Might Reduce the Risk of Basal Cell Carcinoma (July 11, 2012)

Good news for coffee lovers—drinking caffeinated coffee could lower the risk of developing basal cell carcinoma, according to the results of a study published in Cancer Research. The Harvard study found that increased caffeine intake was associated... Continue Reading

Erivedge Effective in Basal-Cell Carcinoma (June 21, 2012)

The targeted agent Erivedge™ (vismodegib) is associated with tumor responses in patients with locally advanced or metastatic basal-cell carcinoma and may even reduce the rate of new basal-cell carcinomas, according to the results of two studies published... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Erivedge Approved for Basal Cell Skin Cancer (February 1, 2012)

The US Food and Drug Administration (FDA) has approved the targeted therapy Erivedge™ (vismodegib) for the treatment basal cell carcinoma of the skin that has spread to other parts of the body or that is locally advanced and cannot be treated with surgery... Continue Reading

Increased Skin Cancer Risk Among Those with Inflammatory Bowel Disease (November 29, 2011)

People with inflammatory bowel disease (IBD) may be at increased risk of non-melanoma skin cancer, particularly if they receive immune-suppressing medications such as thiopurines. These were the results of two studies published in Gastroenterology. Crohn’s... Continue Reading

More General Skin Cancer

General Thyroid Cancer

Selumetinib May Reverse Radioiodine Resistance in Advance Thyroid Cancer (March 28, 2013)

The experimental drug selumetinib (AZD6244) may help some patients with advanced thyroid cancer overcome resistance to radioiodine, which is the most effective treatment for the disease, according to the results of a study published in the New England... Continue Reading

Targeted Drug Caprelsa Slows Thyroid Cancer (August 30, 2012)

The targeted drug Caprelsa® (vandetanib) delays progression in advanced differentiated thyroid cancer, according to the results of a study published in The Lancet Oncology. The thyroid is a gland in the throat that produces hormones mostly related to... Continue Reading

Gene Expression Test Identifies Low-Risk Thyroid Nodules (June 28, 2012)

A new test measures gene expression in thyroid nodules with inconclusive biopsy results and helps identify low-risk nodules, thereby preventing unnecessary surgeries, according to the results of a study published early online in the New England Journal... Continue Reading

Low-Dose Radioiodine Effective in Thyroid Cancer (May 10, 2012)

Low-dose radioiodine is as effective as high-dose in the treatment of thyroid cancer, according to the results of two separate studies published in the New England Journal of Medicine. The results mean that radiation doses could be cut to one-third of... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

More General Thyroid Cancer

General Vaginal Cancer

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

DES Daughters Have Increased Risk of Cancer (October 18, 2011)

According to a study published in the New England Journal of Medicine, women exposed to diethylstilbestrol (DES) before birth have an increased risk of vaginal cancer, cervical precancers, and breast cancer. These women also have an increased risk for... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading

Tumor Burden in Sentinel Node May Help Stratify High- and Low-risk Vulvar Cancer Patients (June 15, 2010)

Tumor burden in the sentinel node of early-stage vulvar cancer patients appears to be an important prognostic factor. Patients with sentinel-node metastasis larger than 2mm may have a worse prognosis. These findings were recently published in the journal... Continue Reading

More General Vaginal Cancer

Sorry, there are no articles available for this cancer stage.

More H

Hairy Cell Leukemia

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

More Hairy Cell Leukemia

Head and Neck Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Doxepin Reduces Mouth Pain from Radiation for Head and Neck Cancer (November 14, 2012)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

More Head and Neck Cancer

Health and Wellness

Heart Healthy Lifestyle Can Reduce Cancer Risk (April 19, 2013)

Smoking Linked to Increased Risk of Breast Cancer (March 14, 2013)

Women who smoke—and especially those who started smoking prior to the birth of their first child—have an increased risk of breast cancer, according to the results of a study published in the Journal of the National Cancer Institute. The study indicates... Continue Reading

Familial Cancer Risk Present in Both Young and Older Diagnosis (January 30, 2013)

Hormone Replacement Therapy in Newly Menopausal Women May Carry More Benefit Than Risk (October 26, 2012)

Hormone replacement therapy for newly menopausal women may not be as risky as once believed, according to the results of a study presented at the 23rd annual meeting of the North American Menopause Society in Orlando, Florida in October 2012.[1] In fact,... Continue Reading

Multivitamins May Cut Cancer Risk (October 25, 2012)

Daily supplementation with multivitamins modestly but significantly reduced the risk of cancer in healthy male doctors who took them for more than 10 years, according to the results of a study published in the Journal of the American Medical Association. The... Continue Reading

More Health and Wellness

Hepatocellular Carcinoma Liver Cancer

Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (November 26, 2012)

Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to the results of a study published in the Journal of the... Continue Reading

Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)

In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were published in Lancet Oncology. Hepatocellular carcinoma... Continue Reading

Women with Hypothyroidism at Increased Risk of Liver Cancer (June 22, 2009)

Women with Hypothyroidism at Increased Risk of Liver Cancer Long-term hypothyroidism in women significantly increases the risk of developing hepatocellular carcinoma (liver cancer), according to the results of a study published in Hepatology.[1] The liver... Continue Reading

Increased Risk of Liver Cancer for Patients with Cirrhosis Who Overexpress EGF (March 8, 2009)

Increased Risk of Liver Cancer for Patients with Cirrhosis Who Overexpress EGF According to an article recently published in the Journal of the American Medical Association, patients with cirrhosis of the liver who overexpress epithelial growth factor... Continue Reading

Nexavar® Added to Treatment Guidelines for Liver Cancer (March 8, 2009)

Nexavar® Added to Treatment Guidelines for Liver Cancer The drug Nexavar® (sorafenib) has been added to the list of treatment options for patients with liver cancer who are not eligible for a liver transplant. This was reported in a recent presentation... Continue Reading

More Hepatocellular Carcinoma Liver Cancer

Highly Aggressive/High Grade Non-Hodgkin's Lymphoma

Lymphoma During Pregnancy Can Have Good Outcomes (March 14, 2012)

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

Survivors of Some Childhood Cancers May Face Cognitive Impairment (May 18, 2010)

Children and Teens Have Better NHL Survival than Young Adults (March 15, 2010)

Even after accounting for stage at diagnosis and subtype of non-Hodgkin’s lymphoma (NHL), children and teens with NHL have better survival than young adults with NHL. These results were published in the Archives of Pediatrics and Adolescent Medicine. Non-Hodgkin’s... Continue Reading

New and Novel Agents for the Treatment of Non-Hodgkin’s Lymphoma: A Report from the 2008 Meeting of the American Society of Hematology (March 8, 2009)

New and Novel Agents for the Treatment of Non-Hodgkin’s Lymphoma: A Report from the 2008 Meeting of the American Society of Hematology The 2008 ASH meeting featured several reports of new agents that are showing promise in the treatment of Non-Hodgkin’s... Continue Reading

More Highly Aggressive/High Grade Non-Hodgkin's Lymphoma

HIV Related Cancers

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Do Complementary Therapies Work? – Ask the expert about herbs, acupuncture, and other complementary therapies (November 4, 2011)

Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service; Laurance S. Rockefeller Chair Integrative Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), click here for Dr. Cassileth’s bio Dr. Cassileth is a world-renowned... Continue Reading

More HIV Related Cancers

Hodgkin's Lymphoma

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Children with Favorable-Risk Hodgkin’s Lymphoma May Benefit from Limited Radiation Therapy (July 6, 2012)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

More Hodgkin's Lymphoma

Hormonal Therapy

Sorry, there are no articles available for this cancer stage.

More Hormonal Therapy

Sorry, there are no articles available for this cancer stage.

More I

Indolent/Low Grade Non-Hodgkin's Lymphoma

Fractionated Zevalin Effective First-Line Treatment for Advanced Follicular Lymphoma (February 8, 2013)

Zevalin Effective as First-Line Treatment for Advanced Follicular Lymphoma (February 1, 2013)

Zevalin Effective in Follicular NHL Refractory to Rituximab (January 24, 2013)

Consolidation with Zevalin Significantly Improves Progression-Free Survival in Advanced Follicular Lymphoma (January 10, 2013)

Several Effective Treatment Options for Early Follicular Lymphoma (September 4, 2012)

The results of a recent study published in the Journal of Clinical Oncology challenge the standard treatment approach for follicular lymphoma—indicating that with proper staging at diagnosis, there are several treatment regimens that can bring a remission. Non-Hodgkin’s... Continue Reading

More Indolent/Low Grade Non-Hodgkin's Lymphoma

Inflammatory Breast Cancer

Radiation for Breast Cancer Increases Risk of Heart Disease and Heart Attack (March 27, 2013)

Exposure to ionizing radiation during radiation therapy for breast cancer may increase the risk of heart attack or heart disease later in life, according to the results of a study published in the New England Journal of Medicine. Many women with breast... Continue Reading

Increase in Number of Women Undergoing Reconstruction Immediately after Mastectomy (January 22, 2013)

There has been a dramatic increase in the number of women undergoing immediate breast reconstruction after mastectomy—and this increase correlates with an increase in the use of implants, according to the results of a study published in Plastic and... Continue Reading

High Breast Density Does Not Increase Risk of Breast Cancer Death (August 29, 2012)

Although high mammographic breast density is associated with an increased risk of developing cancer, it does not appear to increase the risk of death among breast cancer patients, according to the results of a study published in the Journal of the National... Continue Reading

Afinitor Approved for Advanced Breast Cancer (July 31, 2012)

The U.S. Food and Drug Administration (FDA) has approved Afinitor® (everolimus) for use in combination with Aromasin® (exemestane) to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. The combination is... Continue Reading

Physical Activity Linked to Reduced Mortality in Breast and Colon Cancer (May 22, 2012)

More Inflammatory Breast Cancer

Info Type

Sorry, there are no articles available for this cancer stage.

More Info Type

Sorry, there are no articles available for this cancer stage.

More J

Sorry, there are no articles available for this cancer stage.

More K

Sorry, there are no articles available for this cancer stage.

More L

Leukemia

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

CPX-351 Highly Active in Older Patients with AML (January 18, 2013)

Combination of Revlimid and Vidaza Beneficial in Untreated Elderly Patients with AML (January 14, 2013)

Tasigna Superior to Gleevec for Philadelphia Chromosome-Positive CML (December 21, 2012)

More Leukemia

Limited Disease Lung Cancer - Small Cell

Prophylactic Cranial Irradiation May Improve Survival in Small Cell Lung Cancer (June 14, 2011)

Most Survivors of Lung and Colorectal Cancer Keep Their Jobs (April 15, 2010)

Smoking Cessation After Lung Cancer Diagnosis Improves Survival (February 11, 2010)

Quitting smoking after a diagnosis of early-stage lung cancer may reduce the risk of cancer recurrence and death. These results were published in the British Medical Journal. Lung cancer is the leading cause of cancer death in the United States, with... Continue Reading

November Is National Lung Cancer Awareness Month (November 6, 2009)

As the month of November brings lung cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated lung cancer information... Continue Reading

Thalidomide Doesn’t Benefit Patients with Small Cell Lung Cancer (July 22, 2009)

Treatment with a combination of thalidomide and chemotherapy did not improve survival among patients with small cell lung cancer, and resulted in a higher risk of blood clots than treatment with chemotherapy alone. The results of this study were published... Continue Reading

More Limited Disease Lung Cancer - Small Cell

Liver Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Statins Linked to Lower Risk of Liver Cancer in Hepatitis C (May 8, 2013)

People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking statins (cholesterol-lowering drugs), according to the results of a study published in the Journal of Clinical Oncology.[1] The liver is the largest organ... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (November 26, 2012)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

More Liver Cancer

Locally Advanced Stage III (C) Prostate Cancer

Genomic Test May Help Guide Prostate Cancer Treatment (May 13, 2013)

Early Radiation Improves Prostate Cancer Survival (March 7, 2013)

Immediate radiation therapy after radical prostatectomy resulted in a 50 percent increase in long-term biochemical progression-free survival (bNED) in men with locally advanced prostate cancer, according to the results of a study presented at the Genitourinary... Continue Reading

No Difference in Toxicity Between Proton Therapy and IMRT for Prostate Cancer (January 28, 2013)

Viagra Improves Sexual Function after Radiation for Prostate Cancer (November 15, 2012)

Intermittent and Continuous Hormone Therapy are Equally Effective in Prostate Cancer Treatment (September 18, 2012)

More Locally Advanced Stage III (C) Prostate Cancer

Lung Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Screening Could Reduce Lung Cancer Mortality (April 24, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Xgeva Improves Survival Over Zometa in Advanced Lung Cancer (November 28, 2012)

Female Lung Cancer Deaths on the Rise in Some Areas (July 3, 2012)

More Lung Cancer

Lung Cancer - Non-Small Cell

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Screening Could Reduce Lung Cancer Mortality (April 24, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Xgeva Improves Survival Over Zometa in Advanced Lung Cancer (November 28, 2012)

Stereotactic Body Radiation Improves Lung Cancer Survival (November 9, 2012)

Stereotactic body radiation for early-stage, inoperable non-small cell lung cancer yields high overall survival rates and low toxicity compared to conventional radiotherapy, according to the results of a study presented at the annual meeting of the American... Continue Reading

More Lung Cancer - Non-Small Cell

Lung Cancer - Small Cell

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Screening Could Reduce Lung Cancer Mortality (April 24, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Xgeva Improves Survival Over Zometa in Advanced Lung Cancer (November 28, 2012)

Female Lung Cancer Deaths on the Rise in Some Areas (July 3, 2012)

More Lung Cancer - Small Cell

Lymphoma

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Zevalin Plus BEAM Chemotherapy Superior to BEAM Alone in Aggressive Lymphoma (March 22, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Zevalin Effective in Follicular NHL Refractory to Rituximab (January 24, 2013)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

More Lymphoma

Sorry, there are no articles available for this cancer stage.

More M

Management and Prevention of Anemia Supportive Care

Exercise Reduces Chemotherapy-related Fatigue (October 21, 2009)

Exercise reduces fatigue and improves strength, physical functioning, and emotional well-being in men and women undergoing chemotherapy, according to the results of a study published in the British Medical Journal.[1] While exercise has long been associated... Continue Reading

More Management and Prevention of Anemia Supportive Care

Management and Prevention of Anorexia and Weight Loss Supportive Care

Fish Oil May Help Patients Maintain Weight During Chemotherapy (March 8, 2011)

Fish oil, taken as a dietary supplement, may help prevent muscle and weight loss among cancer patients who are undergoing chemotherapy. These findings were reported in the journal Cancer. Loss of muscle and weight is a potential side effect of chemotherapy... Continue Reading

More Management and Prevention of Anorexia and Weight Loss Supportive Care

Management and Prevention of Bone Complications Supportive Care

Xgeva Reduces Bone Complications From Prostate Cancer (February 25, 2011)

Among men with bone metastases from prostate cancer, Xgeva™ (denosumab) was more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. Results from this Phase III clinical trial were published in The... Continue Reading

Xgeva Delays Bone Complications in Women with Metastatic Breast Cancer (December 21, 2010)

In a study of women with bone metastases from breast cancer, Xgeva™ (denosumab) delayed bone complications for five months longer than Zometa® (zoledronic acid). These updated results from a Phase III clinical trial were presented at the 2010 San Antonio... Continue Reading

Denosumab Delays Bone Complications in Women with Metastatic Breast Cancer (November 23, 2010)

Among women with bone metastases from breast cancer, denosumab may be more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. The results of this Phase III clinical trial were published in the Journal... Continue Reading

Denosumab More Effective Than Zometa at Delaying Bone Complications (October 15, 2010)

Among patients with multiple myeloma or bone metastases from breast cancer, prostate cancer, or other solid tumors, denosumab was more effective than Zometa® (zoledronic acid) at delaying or preventing bone complications such as fracture. Results from... Continue Reading

Bisphosphonates May Provide Breast Cancer Benefits (December 11, 2009)

Studies presented at the 2009 San Antonio Breast Cancer Symposium suggest that the class of bone drugs known as bisphosphonates may reduce the risk of breast cancer and may help to maintain bone density in breast cancer patients treated with aromatase... Continue Reading

More Management and Prevention of Bone Complications Supportive Care

Management and Prevention of Fatigue Supportive Care

Exercise Reduces Cancer-Related Fatigue (November 30, 2012)

Yoga Improves Sleep and Quality of Life (May 26, 2010)

A four-week yoga program that included breathing, meditation, postures, and other techniques improved sleep and quality of life among cancer survivors. The results of this study will be presented at the 2010 annual meeting of the American Society of Clinical... Continue Reading

More Management and Prevention of Fatigue Supportive Care

Management and Prevention of Mucositis Supportive Care

Kepivance Reduces Toxicity of High-dose Therapy for Multiple Myeloma (March 24, 2010)

Oral Spray Reduces Mouth Sores (July 21, 2009)

Among patients treated with radiation therapy for head and neck cancer, mouth sores (oral mucositis) were reduced by use of an oral spray containing epidermal growth factor (EGF). These results were published in Cancer. Mouth sores are one of the most... Continue Reading

More Management and Prevention of Mucositis Supportive Care

Management and Prevention of Nausea and Vomiting Supportive Care

Study Suggests Long-acting Patch that Prevents Nausea and Vomiting Can Be Given in Combination with Intravenous Medication (February 9, 2010)

Use of a combination of Sancuso® (granisetron transdermal system; a patch that delivers granisetron through the skin for up to five days) and intravenous granisetron appears to be safe and feasible. This approach may provide immediate and extended... Continue Reading

More Management and Prevention of Nausea and Vomiting Supportive Care

Management and Prevention of Neutropenia Supportive Care

Neulasta Significantly Reduces Febrile Neutropenia Among Colorectal Cancer Patients Receiving Chemotherapy Plus Avasatin (February 25, 2013)

Naproxen May Relieve Bone Pain Associated with Neulasta (August 2, 2012)

Twice-daily naproxen is effective in reducing the incidence and severity of bone pain associated with the use of Neulasta® (pegfilgrastim), according to the results of a study published in the Journal of Clinical Oncology. Neulasta is a blood cell growth... Continue Reading

Celebrities Stand Up to Cancer (September 14, 2009)

Celebrities and Amgen are joining forces to Stand Up to Cancer™—in the form of a public service campaign designed to educate cancer patients and caregivers about managing the increased risk of infection during cancer treatment. Chemotherapy is an... Continue Reading

Amgen Helps Reduce Out-of-pocket Costs for Neulasta® (July 3, 2009)

Amgen’s Neulasta FIRST STEP™ Program provides assistance to eligible, low-income, commercially-insured chemotherapy patients who need help with their co-insurance or co-payment requirement for Neulasta® (pegfilgrastim). Neulasta is a blood cell growth... Continue Reading

More Management and Prevention of Neutropenia Supportive Care

Management and Prevention of Thrombocytopenia Supportive Care

Nplate Produces Rapid Response in Adults with ITP (December 20, 2011)

Among adults with low platelet counts or bleeding symptoms from primary immune thrombocytopenia (ITP), treatment with Nplate® (romiplostim) produces a rapid increase in platelet counts. These results were presented at the 53rd Annual Meeting of the American... Continue Reading

Nplate Active for More than Five Years in Adults with Chronic ITP (December 13, 2010)

Nplate® (romiplostim) appears to maintain platelet counts among adult patients with chronic immune (idiopathic) thrombocytopenia purpura (ITP) for more than five years. These results were presented at the 52nd Annual Meeting and Exposition of the American... Continue Reading

Nplate Reduces Treatment Failure and Splenectomy in Patients with ITP (November 17, 2010)

Compared with standard therapies, Nplate® (romiplostim) appears to reduce the risk of treatment failure and need for splenectomy among adult patients with chronic immune thrombocytopenia (ITP). These results were published in the New England Journal... Continue Reading

Nplate Evaluated in Children with Chronic ITP (December 9, 2009)

Among children with chronic immune thrombocytopenic purpura (ITP; an autoimmune disorder characterized by low platelet counts), treatment with Nplate® (romiplostim) stimulates platelet production and appears to be well tolerated. These results were presented... Continue Reading

More Management and Prevention of Thrombocytopenia Supportive Care

Mantle Cell Non-Hodgkin's Lymphoma

R-CHOP Induction Plus Rituxan Maintenance Improves Remission in Older Patients with Mantle Cell Lymphoma (October 23, 2012)

Induction therapy with R-CHOP followed by maintenance with Rituxan® (rituximab) nearly doubled the remission duration in older patients with mantle cell lymphoma, according to the results of a study published in the New England Journal of Medicine. Non-Hodgkin’s... Continue Reading

Treanda More Effective than Standard R-CHOP for Non-Hodgkin’s Lymphoma (June 12, 2012)

The combination of Treanda® (bendamustine) and Rituxan® (rituximab) more than doubled progression-free survival compared with standard R-CHOP therapy among patients with indolent lymphoma and mantle cell lymphoma, according to the results of a multi-center,... Continue Reading

Lymphoma During Pregnancy Can Have Good Outcomes (March 14, 2012)

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

Survivors of Some Childhood Cancers May Face Cognitive Impairment (May 18, 2010)

More Mantle Cell Non-Hodgkin's Lymphoma

Melanoma

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Lymphoseek Approved for Detecting Lymph Nodes in Breast Cancer and Melanoma (April 10, 2013)

The U.S. Food and Drug Administration (FDA) has approved Lymphoseek® (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing... Continue Reading

Aspirin Reduces Risk of Melanoma in Women (March 20, 2013)

Women who regularly take aspirin have a reduced risk of developing melanoma, according to the results of a study published in Cancer.[1] What’s more—the longer they take the aspirin, the lower the risk. Of the more than one million new diagnoses of... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Combined Targeted Therapy Safe and Effective in Metastatic Melanoma (October 24, 2012)

Treatment with a combination of two targeted agents—dabrafenib, which targets BRAF, and trametinib, which targets MEK—in patients with metastatic melanoma and BRAF V600 mutations was safe and improved progression-free survival, according to the results... Continue Reading

More Melanoma

Mesothelioma

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Do Complementary Therapies Work? – Ask the expert about herbs, acupuncture, and other complementary therapies (November 4, 2011)

More Mesothelioma

Metastatic Breast Cancer

Radiation for Breast Cancer Increases Risk of Heart Disease and Heart Attack (March 27, 2013)

Kadcyla Approved for HER2-Positive Metastatic Breast Cancer (March 19, 2013)

The U.S. Food and Drug Administration (FDA) has approved Kadcyla™ (ado-trastuzumab emtansine, formerly known as T-DM1) for the treatment of HER2-positive, metastatic breast cancer that has been previously treated with Herceptin® (trastuzumab) and taxanes,... Continue Reading

Copper Depletion May Reduce Spread of Triple-Negative Breast Cancer (March 4, 2013)

In a Phase II clinical trial, an anti-copper drug has shown promising results against triple-negative breast cancer. These results were published in the Annals of Oncology. Studies have suggested that bone marrow cells known as endothelial progenitor... Continue Reading

Increase in Number of Women Undergoing Reconstruction Immediately after Mastectomy (January 22, 2013)

Investigational Agent Demonstrates Benefit in Advanced ER-Positive Breast Cancer (December 12, 2012)

The combination of Femara® (letrozole) and the investigational agent PD 0332991 significantly improved median progression-free survival in patients with advanced estrogen receptor-positive (ER-positive) breast cancer, according to the results of a study... Continue Reading

More Metastatic Breast Cancer

Metastatic Stage IV (D) Prostate Cancer

Genomic Test May Help Guide Prostate Cancer Treatment (May 13, 2013)

No Difference in Toxicity Between Proton Therapy and IMRT for Prostate Cancer (January 28, 2013)

Zytiga Approval Expanded (December 17, 2012)

The U.S. Food and Drug Administration (FDA) has expanded the approved use of Zytiga® (abiraterone) to treat men with metastatic, hormone-refractory prostate cancer prior to receiving chemotherapy. Prostate cancer is a hormonally sensitive disease that... Continue Reading

Intermittent and Continuous Hormone Therapy are Equally Effective in Prostate Cancer Treatment (September 18, 2012)

Xtandi Approved for Metastatic Hormone-Refractory Prostate Cancer (September 13, 2012)

The U.S. Food and Drug Administration (FDA) has approved Xtandi® (enzalutamide) for the treatment of patients with metastatic, hormone-refractory prostate cancer who have previously received docetaxel. The prostate is a male sex gland responsible for... Continue Reading

More Metastatic Stage IV (D) Prostate Cancer

Metastatic/Stage IVB Cervical Cancer

January Is National Cervical Cancer Awareness Month (March 8, 2009)

January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading

Updates in the Management of Gynecologic Cancers (May 27, 2008)

Updates in the Management of Gynecologic Cancers: A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists The 39th Annual Meeting of the Society of Gynecologic Oncologists (SGO) was held in Tampa, Florida, from March 9 to 12, 2008,... Continue Reading

More Metastatic/Stage IVB Cervical Cancer

Miscellaneous

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

More Miscellaneous

Multiple Myeloma

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Pomalyst Approved for Advanced Multiple Myeloma (March 13, 2013)

The U.S. Food and Drug Administration (FDA) has approved Pomalyst® (pomalidomide) for the treatment of patients with multiple myeloma whose disease progressed after being treated with other cancer drugs. Multiple myeloma is a cancer of plasma cells,... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Zevalin Effective in Relapsed/Refractory Follicular Lymphoma (January 11, 2013)

Pomalidomide plus low-dose dexamethasone (LoDEX) significantly increased progression-free survival and overall survival compared with high-dose dexamethasone (HiDEX) in patients with refractory multiple myeloma, according to the results of a phase III... Continue Reading

Pomalidomide Improves Survival in Refractory Multiple Myeloma (January 8, 2013)

More Multiple Myeloma

Myelodysplastic Syndrome

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Do Complementary Therapies Work? – Ask the expert about herbs, acupuncture, and other complementary therapies (November 4, 2011)

More Myelodysplastic Syndrome

Sorry, there are no articles available for this cancer stage.

More N

Neuroblastoma

Cancer Deaths on the Decline (February 11, 2013)

Targeted Agent Xalkori May Benefit Children with Anaplastic Lymphoma (May 23, 2012)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Do Complementary Therapies Work? – Ask the expert about herbs, acupuncture, and other complementary therapies (November 4, 2011)

More Neuroblastoma

News

Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer (May 17, 2013)

A novel two-step immunotherapy approach yielded clinically beneficial responses in patients with advanced ovarian cancer, according to data from two phase I clinical trials presented at the American Association for Cancer Research (AACR) Annual Meeting... Continue Reading

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Genomic Test May Help Guide Prostate Cancer Treatment (May 13, 2013)

Statins Linked to Lower Risk of Liver Cancer in Hepatitis C (May 8, 2013)

Anal Cancer Rates Appear to Be On the Rise in the U.S. (May 6, 2013)

More News

Non-Hodgkin's Lymphoma

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

RIT Conditioning with Zevalin Prior to Autologous Transplantation Improves Overall Survival in Patients with DLCL (April 5, 2013)

Treanda Plus Rituxan is Not Inferior to R-CHOP and R-CVP for advanced NHL (April 2, 2013)

Zevalin Plus Nonmyeloablative Allogeneic Transplantation Effective in High-Risk B-Cell NHL (March 29, 2013)

Zevalin Plus BEAM Chemotherapy Superior to BEAM Alone in Aggressive Lymphoma (March 22, 2013)

More Non-Hodgkin's Lymphoma

Sorry, there are no articles available for this cancer stage.

More O

Osteosarcoma

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Do Complementary Therapies Work? – Ask the expert about herbs, acupuncture, and other complementary therapies (November 4, 2011)

Clinical Trial Participation Is Inadequate (August 31, 2011)

A large proportion of cancer patients do not enroll in clinical trials, and those who do participate may not adequately represent age groups, cancer stages, cancer types, and racial and ethnic groups. These findings were recently reported in the Annals... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

Survivors of Childhood Cancer Face Risk of More Cancer (July 11, 2011)

Children who survive cancer have an increased risk of developing cancer later in life. These findings were recently reported in the Journal of Clinical Oncology. The good news about childhood cancer is that increasingly more children are surviving. These... Continue Reading

More Osteosarcoma

Other News Topics (not Types of Cancer)

Number of Cancer Survivors Expected to Reach 18 Million by 2022 (May 1, 2013)

Heart Healthy Lifestyle Can Reduce Cancer Risk (April 19, 2013)

Mutation in Immortality Gene Linked to Brain and Other Tumors (April 17, 2013)

Exercise Reduces Cancer-Related Fatigue (November 30, 2012)

U.S. Will Cover Cancer Treatment for 9/11 Responders (September 20, 2012)

The National Institute for Occupational Safety and Health has announced that responders and survivors exposed to toxic compounds from the 9/11 wreckage at the World Trade Center (WTC) and the Pentagon are entitled to free monitoring and treatment for... Continue Reading

More Other News Topics (not Types of Cancer)

Ovarian Cancer

Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer (May 17, 2013)

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Delaying Chemotherapy Increases Mortality in Ovarian Cancer (April 12, 2013)

Women with advanced ovarian cancer have significantly worse survival when they wait more than 25 days after surgery to start chemotherapy, according to the results of a study presented at the 2013 Society of Gynecologic Oncology Annual Meeting on Women’s... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)

The rate of second primary ovarian cancers after first primary breast cancer appears to be on the decline, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, roughly 22,000 women are diagnosed... Continue Reading

More Ovarian Cancer

Sorry, there are no articles available for this cancer stage.

More P

Pain Management Supportive Care

Acupuncture Relieves Pain, Improves Functioning After Neck Surgery (April 29, 2010)

Acupuncture may reduce pain and improve functioning among patients with cancer who have undergone surgery to the neck, according to a study published in the Journal of Clinical Oncology.[1] As well, acupuncture may relieve xerostomia (dry mouth) among... Continue Reading

Onsolis Approved for Breakthrough Pain (July 28, 2009)

Onsolis (fentanyl buccal soluble film) has been approved by the U.S. Food and Drug Administration for the treatment of breakthrough cancer pain.[1] Pain may be a side effect of cancer treatment or may be caused by the cancer itself. If not adequately... Continue Reading

More Pain Management Supportive Care

Pancreatic Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Abraxane Improves Survival in Pancreatic Cancer (February 13, 2013)

Abraxane® (nab-paclitaxel) prolonged life in patients with metastatic pancreatic cancer by an average of two months longer than chemotherapy and significantly increased the percentage of patients who survived for up to two years, according to the results... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

More Pancreatic Cancer

Progressive Relapsed Hodgkin's Lymphoma

Adcetris Approved for Two Types of Lymphoma (August 26, 2011)

The targeted therapy Adcetris™ (brentuximab vedotin) has received accelerated approved by the US Food and Drug Administration (FDA) for the treatment of two types of lymphoma: Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL). Hodgkin... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

Targeted Therapy Promising for Relapsed Hodgkin Lymphoma (January 12, 2011)

In a Phase II clinical trial, three-quarters of patients with relapsed or refractory Hodgkin lymphoma responded to treatment with the investigational drug brentuximab vedotin. These results were presented at the 2010 annual meeting of the American Society... Continue Reading

Panobinostat Promising in Relapsed/Refractory Hodgkin’s Lymphoma (November 9, 2010)

An ongoing study of the experimental drug panobinostat (LBH-589) reports promising activity in heavily pretreated patients with relapsed and refractory Hodgkin’s lymphoma (HL). These findings were presented at the 2010 annual meeting of the American... Continue Reading

Allogeneic Stem Cell Transplantation Viable for Children and Adolescents with Relapsed Hodgkin’s Lymphoma (September 24, 2009)

Children and adolescents with relapsed Hodgkin’s lymphoma respond well to allogeneic stem cell transplantation, according to the results of a study published in Blood.[1] Although children and adolescents with Hodgkin’s lymphoma have an excellent... Continue Reading

More Progressive Relapsed Hodgkin's Lymphoma

Prostate Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Genomic Test May Help Guide Prostate Cancer Treatment (May 13, 2013)

Early Radiation Improves Prostate Cancer Survival (March 7, 2013)

Surgery and Radiation for Prostate Cancer Produce Similar Functional Outcomes (February 27, 2013)

Cancer Deaths on the Decline (February 11, 2013)

More Prostate Cancer

Sorry, there are no articles available for this cancer stage.

More Q

Sorry, there are no articles available for this cancer stage.

More R

Radiopharmaceutical

Sorry, there are no articles available for this cancer stage.

More Radiopharmaceutical

Rectal Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)

New Colonoscopy Surveillance Guidelines (October 10, 2012)

The U.S. Multi-Society Task Force on Colorectal Cancer has released a consensus update regarding colonoscopy surveillance—and the guidelines indicate that average-risk patients who have a clean colonoscopy can wait 10 years between exams. Colorectal... Continue Reading

Adjuvant Therapy May Offer Survival Benefit in Older Patients with Colorectal Cancer (September 11, 2012)

More Rectal Cancer

Recurrent Anal Cancer

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

More Recurrent Anal Cancer

Recurrent Bladder Cancer

Robotic Bladder Cancer Surgery Safe and Effective (January 24, 2013)

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Cystoscopy Alone Is the Most Cost-effective Way to Monitor for Recurrence of Bladder Cancer (March 9, 2010)

The addition of a urine test to standard cystoscopy screening in order to monitor for bladder cancer recurrence unnecessarily increases the cost of monitoring as well as the risk for a false-positive result and does not improve tumor detection, according... Continue Reading

More Recurrent Bladder Cancer

Recurrent Breast Cancer

Radiation for Breast Cancer Increases Risk of Heart Disease and Heart Attack (March 27, 2013)

Kadcyla Approved for HER2-Positive Metastatic Breast Cancer (March 19, 2013)

Increase in Number of Women Undergoing Reconstruction Immediately after Mastectomy (January 22, 2013)

Investigational Agent Demonstrates Benefit in Advanced ER-Positive Breast Cancer (December 12, 2012)

Some Evidence of Mild “Chemo Brain” in Breast Cancer Survivors (September 14, 2012)

Breast cancer patients treated with chemotherapy are at risk for mild cognitive deficits (sometimes referred to as chemo brain) after treatment, according to the results of a study published early online in the Journal of Clinical Oncology. A large portion... Continue Reading

More Recurrent Breast Cancer

Recurrent Cervical Cancer

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Avastin® Shows Promise in Treatment of Cervical Cancer (March 8, 2009)

Avastin® Shows Promise in Treatment of Cervical Cancer According to the results of a Phase II clinical trial, the targeted therapy Avastin® (bevacizumab) warrants further investigation in the treatment of persistent or recurrent squamous cell carcinoma... Continue Reading

January Is National Cervical Cancer Awareness Month (March 8, 2009)

Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers (March 8, 2009)

Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective... Continue Reading

More Recurrent Cervical Cancer

Recurrent Gastric Cancer

Second-Line Docetaxel Improves Survival in Esophageal and Gastric Cancer (April 3, 2013)

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Herceptin® Approved for HER2-positive Metastatic Stomach Cancer (November 2, 2010)

The U.S. Food and Drug Administration (FDA) has expanded the approval of Herceptin® (trastuzumab) to include the initial treatment of HER2-positive metastatic cancer of the stomach or gastroesophageal junction in combination with chemotherapy.[1] Herceptin... Continue Reading

Clinical Trial for Advanced Gastric Cancer Now Enrolling Patients (July 16, 2010)

Gastric cancer forms in the tissues and lining of the stomach. Current treatment options include surgery, chemotherapy, and radiation. The current standard of care for metastatic gastric cancer is systemic therapy. Research is ongoing to determine which... Continue Reading

Herceptin® Improves Survival with HER2-positive Gastric Cancer (June 2, 2009)

Herceptin® Improves Survival with HER2-positive Gastric Cancer According to the results of a Phase III clinical trial presented at the 2009 annual meeting of the American Society of Clinical Oncology (ASCO), treatment with a combination of chemotherapy... Continue Reading

More Recurrent Gastric Cancer

Recurrent Liver Cancer

Cabozantinib Shows Promise against Bone Metastases (May 31, 2011)

The investigational drug cabozantinib is showing promise against several types of advanced cancer, and may also reduce or eliminate bone metastases (cancer that has spread to the bone) in some patients. These results will be presented at the 2011 annual... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

More Recurrent Liver Cancer

Recurrent Lung Cancer - Non-Small Cell

Xgeva Improves Survival Over Zometa in Advanced Lung Cancer (November 28, 2012)

Xalkori Superior to Standard Chemotherapy in ALK-Positive Lung Cancer (October 4, 2012)

The targeted therapy Xalkori® (crizotinib) is superior to standard chemotherapy for the treatment of patients with advanced, ALK-positive non-small cell lung cancer, according to the results of a phase III trial presented at the ESMO 2012 Congress of... Continue Reading

Genetic Study Identifies New Targets for Treating Squamous Cell Lung Cancer (September 19, 2012)

Researchers have identified a large variety of genetic alterations that appear to be responsible for the development and growth of squamous cell lung cancer, according to the results of a study published in Nature. The discovery could lead to new targeted... Continue Reading

Two Studies Show Promise in Second-Line Treatments for NSCLC (August 14, 2012)

Two studies presented at the 2012 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Illinois shed new light on the best way to treat non-small cell lung cancer (NSCLC)—one indicating that chemotherapy may be superior to... Continue Reading

PD-1 Targeted Immune Therapy Shows Promising Activity (June 11, 2012)

More Recurrent Lung Cancer - Non-Small Cell

Recurrent Lung Cancer - Small Cell

Xgeva Improves Survival Over Zometa in Advanced Lung Cancer (November 28, 2012)

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

November Is National Lung Cancer Awareness Month (November 6, 2009)

More Recurrent Lung Cancer - Small Cell

Recurrent Melanoma

Combined Targeted Therapy Safe and Effective in Metastatic Melanoma (October 24, 2012)

Adjuvant Radiotherapy for the Management of High-Risk Malignant Melanoma (September 24, 2012)

Adjuvant radiotherapy significantly improved regional lymphatic control for high-risk patients after therapeutic lymphadenectomy for metastatic melanoma, according to the results of a study published in the Lancet Oncology. Of the more than one million... Continue Reading

PD-1 Targeted Immune Therapy Shows Promising Activity (June 11, 2012)

Zelboraf Improves Melanoma Survival (March 16, 2012)

Among patients with previously treated metastatic melanoma that carries a certain gene mutation, the targeted drug Zelboraf® (vemurafenib) resulted in a median overall survival of 16 months. This is a substantial improvement over what has been seen in... Continue Reading

Cabozantinib Shows Promise against Bone Metastases (May 31, 2011)

More Recurrent Melanoma

Recurrent Multiple Myeloma

Pomalyst Approved for Advanced Multiple Myeloma (March 13, 2013)

Zevalin Effective in Relapsed/Refractory Follicular Lymphoma (January 11, 2013)

Pomalidomide Improves Survival in Refractory Multiple Myeloma (January 8, 2013)

MLN9708 “Oral Velcade” Shows Promise in Multiple Myeloma (January 3, 2013)

The investigational, oral proteasome inhibitor MLN9708, which is a new version of Velcade® (bortezomib)—may be more effective and better tolerated than the Velcade injections, according to data from a mid-stage study presented at the 54th Annual Meeting... Continue Reading

Kyprolis Approved for Multiple Myeloma (July 24, 2012)

The U.S. Food and Drug Administration (FDA) has approved Kyprolis™ (carfilzomib) for the treatment of patients with multiple myeloma that has already been treated with at least two prior therapies—including Velcade® (bortezomib) and a drug such as... Continue Reading

More Recurrent Multiple Myeloma

Recurrent Non-Hodgkin's Lymphoma

Adcetris Approved for Two Types of Lymphoma (August 26, 2011)

Brentuximab Vedotin Effective for Patients with Relapsed or Refractory Anaplastic Large Cell Lymphoma (June 16, 2011)

Researchers involved in an international multicenter trial have reported that brentuximab vedotin was effective for treatment of patients with relapsed or refractory anaplastic large cell lymphoma. The details of this study were reported at the 2011 meeting... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

Survivors of Some Childhood Cancers May Face Cognitive Impairment (May 18, 2010)

Children and Teens Have Better NHL Survival than Young Adults (March 15, 2010)

More Recurrent Non-Hodgkin's Lymphoma

Recurrent Ovarian Cancer

Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer (May 17, 2013)

Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)

Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)

Metformin, a widely prescribed insulin-lowering drug for diabetes, has been associated with survival in ovarian cancer and is worthy of further study, as it may be considered for the prevention or treatment of ovarian cancer, according to the results... Continue Reading

Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (November 20, 2012)

Ovarian cancer patients who undergo surgery at high-volume hospitals have better outcomes than those who are treated at low-volume hospitals, according to the results of a study published in the Journal of Clinical Oncology. This is the result not of... Continue Reading

Gene Helps Predict Response to Chemotherapy in Ovarian Cancer (September 28, 2012)

Measuring the activity of a gene called FGF1 could help predict which women with ovarian cancer will benefit from platinum-based chemotherapy, according to the results of a study published in the British Journal of Cancer. Each year in the United States,... Continue Reading

More Recurrent Ovarian Cancer

Recurrent Pancreatic Cancer

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

November Is National Pancreatic Cancer Awareness Month (November 5, 2009)

As the month of November brings pancreatic cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated pancreatic... Continue Reading

More Recurrent Pancreatic Cancer

Recurrent Testicular Cancer

Marijuana May Increase Risk of Testicular Cancer (September 21, 2012)

Recreational marijuana use may increase the risk of developing subtypes of testicular cancer that have a worse prognosis, according to the results of a study published early online in the journal Cancer. Testicular cancer is the most common cancer diagnosed... Continue Reading

Paclitaxel/Gemzar Provides Long-Term Survival in Refractory Testicular Cancer (June 14, 2011)

Treatment with the chemotherapy agents paclitaxel and Gemzar® (gemcitabine) provides long-term survival and possible cure among some patients with testicular cancer that has stopped responding to prior therapies. These results were recently presented... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

More Recurrent Testicular Cancer

Recurrent Uterine Cancer

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers (March 8, 2009)

More Recurrent Uterine Cancer

Recurrent/Relapsed Rectal Cancer

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)

Zaltrap Approved for Metastatic Colorectal Cancer (August 15, 2012)

The U.S. Food and Drug Administration (FDA) has approved Zaltrap® (ziv-aflibercept) for use in combination with the FOLFIRI chemotherapy regimen (folinic acid, fluorouracil, and ironotecan) to treat adults with metastatic colorectal cancer. Colorectal... Continue Reading

Regorafenib Shows Promise Against Metastatic Colorectal Cancer (January 19, 2012)

The investigational drug regorafenib improves survival and delays cancer progression among patients with metastatic colorectal cancer that has worsened in spite of other treatments. These results will be presented at the 2012 Gastrointestinal Cancers... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Study Takes Closer Look at Erbitux Efficacy in Patients with Specific KRAS Mutations (November 8, 2010)

Although colorectal cancer patients with mutations in the KRAS gene tend not to respond to drugs such as Erbitux® (cetuximab), responsiveness may vary by the specific type of KRAS mutation. These results were published in the Journal of the American... Continue Reading

More Recurrent/Relapsed Rectal Cancer

Refactory/Recurrent Prostate Cancer

Genomic Test May Help Guide Prostate Cancer Treatment (May 13, 2013)

No Difference in Toxicity Between Proton Therapy and IMRT for Prostate Cancer (January 28, 2013)

Intermittent and Continuous Hormone Therapy are Equally Effective in Prostate Cancer Treatment (September 18, 2012)

Xtandi Approved for Metastatic Hormone-Refractory Prostate Cancer (September 13, 2012)

Enzalutamide Prolongs Survival in Metastatic Prostate Cancer (August 27, 2012)

Enzalutamide, an experimental androgen receptor antagonist drug, significantly prolongs survival in men with metastatic hormone-refractory prostate cancer after chemotherapy, according to the results of a study published in the New England Journal... Continue Reading

More Refactory/Recurrent Prostate Cancer

Renal Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

New Treatment Options for Advanced Renal Cell Carcinoma (October 8, 2012)

PD-1 Targeted Immune Therapy Shows Promising Activity (June 11, 2012)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

More Renal Cancer

Retinoblastoma

Cancer Deaths on the Decline (February 11, 2013)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Lynch Syndrome Also Linked with Breast and Pancreatic Cancer (February 17, 2012)

Do Complementary Therapies Work? – Ask the expert about herbs, acupuncture, and other complementary therapies (November 4, 2011)

More Retinoblastoma

Sorry, there are no articles available for this cancer stage.

Sarcoma

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Shorter Chemotherapy Intervals Effective in Ewing Sarcoma (November 1, 2012)

Regorafenib May Expand GIST Treatment Options (June 13, 2012)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

More Sarcoma

Screening/Prevention Anal Cancer

Anal Cancer Rates Appear to Be On the Rise in the U.S. (May 6, 2013)

Anal Cancer on the Rise in Men with HIV (October 15, 2012)

HPV Vaccine Reducing Infection among Vaccinated and Unvaccinated (July 16, 2012)

The human papillomavirus (HPV) vaccine is reducing infections of virus strains associated with genital warts and cancer, even among those who remain unvaccinated, according to the results of a study published in Pediatrics. HPV is the most common sexually... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

HPV Vaccine May Prevent Anal Cancer (September 14, 2011)

Cervarix® (human papillomavirus bivalent [types 16 and 18] recombinant vaccine), an FDA-approved vaccine for the prevention of cervical cancer, may also help prevent anal cancer. These findings were recently reported in Lancet Oncology. Human papillomaviruses... Continue Reading

More Screening/Prevention Anal Cancer

Screening/Prevention Bladder Cancer

More Evidence that Diabetes Drugs Increase Risk of Bladder Cancer (August 22, 2012)

Diabetes Drugs May Increase Risk of Bladder Cancer (July 26, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Lynch Syndrome Also Linked with Breast and Pancreatic Cancer (February 17, 2012)

New Data Show Higher Bladder Cancer Risk for Smokers (August 29, 2011)

New data suggest that the risk of bladder cancer among smokers may be higher than previous estimates. And, though women were thought to have a lower rate of smoking-attributable bladder cancer than men, it now appears that smoking accounts for half of... Continue Reading

More Screening/Prevention Bladder Cancer

Screening/Prevention Breast Cancer

False-Positive Mammograms Leave a Long-Term Psychological Impact (May 3, 2013)

Combined Hormone Replacement Therapy Linked to Increased Risk of Breast Cancer (April 26, 2013)

Biennial Mammography is Appropriate for Women Ages 50-74 (April 16, 2013)

Study Explores Breast Cancer Prognosis By Race (April 11, 2013)

Smoking Linked to Increased Risk of Breast Cancer (March 14, 2013)

More Screening/Prevention Breast Cancer

Screening/Prevention Cervical Cancer

HPV Test Appropriate After Indeterminate Pap Test (April 29, 2013)

HPV Vaccination Does Not Lead to Increase in Sex (October 19, 2012)

Vaccination against the human papillomavirus (HPV) does not lead to increased sexual activity, according to the results of a study published in the journal Vaccine. HPV is the most common sexually transmitted infection in the United States. There are... Continue Reading

Gardasil is Safe, According to Large Study (October 12, 2012)

HPV Testing Can Predict Risk of Cervical Cancer for Up to 18 Years (August 8, 2012)

HPV Vaccine Reducing Infection among Vaccinated and Unvaccinated (July 16, 2012)

More Screening/Prevention Cervical Cancer

Screening/Prevention Colon Cancer

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)

Universal Tumor Testing to Identify Lynch Syndrome (October 30, 2012)

Universal tumor MMR testing among patients with colorectal cancer may have a greater sensitivity for identifying Lynch syndrome than other screening strategies, according to the results of a study published in the Journal of the American Medical Association. Lynch... Continue Reading

B Vitamins Do Not Appear to Affect Colorectal Cancer Risk (October 22, 2012)

A combination supplement of folic acid, vitamin B6 and vitamin B12 did not statistically significantly increase or decrease the risk of colorectal cancer in older women, according to the results of a study published in the Journal of the National Cancer... Continue Reading

New Colonoscopy Surveillance Guidelines (October 10, 2012)

Colonoscopy Related Factors Associated with Increased Risk of Cancer (August 31, 2012)

Incomplete polyp removal and failure to have a follow-up colonoscopy within five years after the detection of the first polyp are more strongly associated with an increased risk of developing colorectal cancer than the characteristics of the polyp, according... Continue Reading

More Screening/Prevention Colon Cancer

Screening/Prevention Esophageal Cancer

Esophageal Cancer on the Rise (November 12, 2012)

The rate of esophageal cancer is on the rise worldwide, according to the results of a study published in GUT: An International Journal of Gastroenterology and Hepatology, but the onset and magnitude of the increase varies among countries and even states. The... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Stay on Top of Your Family History of Cancer (July 15, 2011)

Barrett’s Esophagus May Carry Lower Risk of Esophageal Cancer Than Previously Reported (July 8, 2011)

Cancer Risk May Rise Even with Moderate Drinking (April 15, 2011)

People who currently consume alcohol or have done so in the past may have an increased risk of developing cancer, even those who drink moderately. These findings were recently reported in the journal BMJ. Worldwide, an estimated 3.5% of all cancer deaths... Continue Reading

More Screening/Prevention Esophageal Cancer

Screening/Prevention Gastric Cancer

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Lynch Syndrome Also Linked with Breast and Pancreatic Cancer (February 17, 2012)

Alcohol Linked with Stomach Cancer (November 7, 2011)

According to a large European study, men who average more than four alcoholic beverages per day are more likely than light drinkers to develop stomach cancer. These results were published in the American Journal of Clinical Nutrition. Cancer of the stomach... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

Fewer Lung Cancer Deaths Among Women (April 11, 2011)

The lung cancer death rate among women appears to be declining for the first time in 40 years, according to an annual report published by multiple institutions. Findings from the report were recently released in the Journal of the National Cancer Institute. A... Continue Reading

More Screening/Prevention Gastric Cancer

Screening/Prevention Leukemia

Childhood CT Scans Linked to Leukemia and Brain Cancer Later in Life (June 20, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Greater Cancer Risk Among Taller Women (July 28, 2011)

Taller women may have an increased risk of developing certain cancers. Overall, cancer risk increases by 16% for every 4-inch increase in height. These findings were recently reported in Lancet Oncology. Greater insight into height and cancer risk may... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

More Screening/Prevention Leukemia

Screening/Prevention Liver Cancer

Statins Linked to Lower Risk of Liver Cancer in Hepatitis C (May 8, 2013)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Study Identifies Risk Factors Including Hepatitis C and Alcohol for Developing Hepatocellular Carcinoma (Liver Cancer) (March 12, 2012)

Liver cancer incidence has increased over time in the United States, and chronic infection with the hepatitis C virus now plays an important role in many cases. These results were published in Mayo Clinic Proceedings. The liver is the largest organ in... Continue Reading

Organ Transplant Recipients Have Increased Cancer Risk (November 9, 2011)

People who have received a solid organ transplant (such as a kidney or liver) are twice as likely as people in the general population to develop cancer. These results were published in the Journal of the American Medical Association. In 2010, more than... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

More Screening/Prevention Liver Cancer

Screening/Prevention Lung Cancer - Non-Small Cell

Screening Could Reduce Lung Cancer Mortality (April 24, 2013)

Hormone Replacement Therapy in Newly Menopausal Women May Carry More Benefit Than Risk (October 26, 2012)

Female Lung Cancer Deaths on the Rise in Some Areas (July 3, 2012)

Diesel Exhaust Linked to Lung Cancer (June 26, 2012)

New Lung Cancer Screening Guidelines (May 25, 2012)

More Screening/Prevention Lung Cancer - Non-Small Cell

Screening/Prevention Lung Cancer - Small Cell

Screening Could Reduce Lung Cancer Mortality (April 24, 2013)

Female Lung Cancer Deaths on the Rise in Some Areas (July 3, 2012)

Diesel Exhaust Linked to Lung Cancer (June 26, 2012)

New Lung Cancer Screening Guidelines (May 25, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

More Screening/Prevention Lung Cancer - Small Cell

Screening/Prevention Melanoma

Aspirin Reduces Risk of Melanoma in Women (March 20, 2013)

Lymphoma Patients and Transplant Recipients at Higher Risk of Melanoma (October 11, 2012)

Number of Cancer Survivors Will Grow to 18 Million by 2022 (June 25, 2012)

There will be nearly 18 million cancer survivors in the United States by 2022, according to a report by the American Cancer Society and the National Cancer Institute: Cancer Treatment & Survivorship Facts & Figures[1] and an accompanying journal... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Additional Evidence That Tanning Beds Increase Skin Cancer Risk (November 3, 2011)

According to a study of more than 73,000 women, use of tanning beds increases the risk of three common types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. These results were presented at the 10th AACR International Conference... Continue Reading

More Screening/Prevention Melanoma

Screening/Prevention Non-Hodgkin's Lymphoma

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Organ Transplant Recipients Have Increased Cancer Risk (November 9, 2011)

Greater Cancer Risk Among Taller Women (July 28, 2011)

Stay on Top of Your Family History of Cancer (July 15, 2011)

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

More Screening/Prevention Non-Hodgkin's Lymphoma

Screening/Prevention Ovarian Cancer

Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)

Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)

Aspirin May Reduce Risk of Serous Ovarian Cancer (October 18, 2012)

Women who regularly use aspirin may have a decreased risk of developing serous ovarian cancer, according to the results of a study published in Acta Obstetricia et Gynecologica Scandinavica. Ovarian cancer has the highest mortality rate of all gynecologic... Continue Reading

Healthy Women Need Not Undergo Screening for Ovarian Cancer (April 19, 2012)

Healthy women at average risk for ovarian cancer do not need to get screened for the disease, according to the U.S. Preventive Services Task Force (USPSTF). After a recent review of the data, the government panel has renewed its 2004 recommendation against... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

More Screening/Prevention Ovarian Cancer

Screening/Prevention Pancreatic Cancer

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Lynch Syndrome Also Linked with Breast and Pancreatic Cancer (February 17, 2012)

Test Holds Promise for Early Detection of Pancreatic Cancer (January 24, 2012)

A test that detects a particular protein in the blood (PAM4) correctly identified roughly two-thirds of patients with early-stage pancreatic cancer. These results were presented at the 2012 Gastrointestinal Cancers Symposium. Pancreatic cancer is one... Continue Reading

Processed Meat Linked with Increased Risk of Pancreatic Cancer (January 18, 2012)

Eating processed meat such as sausage or bacon appears to increase the risk of pancreatic cancer. These results were published in the British Journal of Cancer. Pancreatic cancer is one of the deadliest forms of cancer. Each year, close to 44,000 people... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

More Screening/Prevention Pancreatic Cancer

Screening/Prevention Prostate Cancer

Prostate Cancer Screening Can Take a Toll on Quality of Life (December 19, 2012)

Screening for prostate cancer carries some risks and can affect quality of life. Considering these risks is important when making the decision about whether to be screened. The results of a study that assessed both the potential benefits of screening... Continue Reading

Aspirin and Cancer Risk and Mortality (September 17, 2012)

Aspirin and cancer risk is in the news again—and the link is still unclear. Two studies published early online in the Journal of Clinical Oncology evaluated the relationship between aspirin and cancer risk—one indicated that aspirin does not appear... Continue Reading

New Screening Method May Help Diagnose Undetectable Prostate Cancer (August 16, 2012)

Men with persistently increased or fluctuating prostate specific antigen (PSA) levels and a negative prostate biopsy may benefit from a new prostate cancer screening method that uses the combination of a novel drug therapy plus changes in PSA levels over... Continue Reading

PSA Testing May Be Appropriate for Some Men (July 25, 2012)

The American Society of Clinical Oncology (ASCO) has released a Provisional Clinical Opinion (PCO) suggesting that that men with a longer life expectancy—those with at least 10 more years to live—discuss with their physician the potential risks and... Continue Reading

Side Effects of Prostate Cancer Treatment Persist Long-Term (July 5, 2012)

Men who are treated for prostate cancer may continue to suffer from side effects 10 years after treatment, according to the results of a study published in the Journal of Clinical Oncology. Each year in the United States, more than 192,000 men are diagnosed... Continue Reading

More Screening/Prevention Prostate Cancer

Screening/Prevention Rectal Cancer

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)

New Colonoscopy Surveillance Guidelines (October 10, 2012)

Sigmoidoscopy Screening Reduces Colorectal Cancer Incidence and Mortality (May 29, 2012)

Sigmoidoscopy, a less-invasive screening procedure that examines the lower portion of the bowel, can reduce the risk of developing colorectal cancer or dying from it, according to the results of a study published in the New England Journal of Medicine. Colorectal... Continue Reading

Providing Screening Choices Improves Adherence to Colorectal Cancer Screening (April 16, 2012)

Individuals are much more likely to get screened for colorectal cancer when given a choice between colonoscopy and fecal occult blood test (FOBT), according to the results of a study published in the Archives of Internal Medicine.[1] Screening is crucial... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

More Screening/Prevention Rectal Cancer

Screening/Prevention Uterine Cancer

Number of Cancer Survivors Will Grow to 18 Million by 2022 (June 25, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Lynch Syndrome Also Linked with Breast and Pancreatic Cancer (February 17, 2012)

Myotonic Muscular Dystrophy Linked with Increased Cancer Risk (December 19, 2011)

People with myotonic muscular dystrophy may be more likely than people in the general population to develop certain types of cancer. These results were published in the Journal of the American Medical Association. Myotonic muscular dystrophy (MMD) is... Continue Reading

Coffee May Cut Uterine Cancer Risk (November 30, 2011)

Women who consume four or more cups a coffee per day may have a lower risk of endometrial cancer (cancer of the lining of the uterus) than women who drink very little or no coffee. These results were published in Cancer Epidemiology, Biomarkers, &... Continue Reading

More Screening/Prevention Uterine Cancer

Skin Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Coffee Might Reduce the Risk of Basal Cell Carcinoma (July 11, 2012)

Erivedge Effective in Basal-Cell Carcinoma (June 21, 2012)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

More Skin Cancer

Skin Cancer Overview

Sorry, there are no articles available for this cancer stage.

More Skin Cancer Overview

Soft Tissue Sarcomas

Regorafenib May Expand GIST Treatment Options (June 13, 2012)

More Soft Tissue Sarcomas

Stage I Cervical Cancer

Sentinel Node Biopsy Is a Minimally-invasive, Effective Method for Determining Spread of Cervical Cancer (June 9, 2009)

Sentinel Node Biopsy Is a Minimally-invasive, Effective Method for Determining Spread of Cervical Cancer The majority of women with cervical cancer can safely undergo sentinel node biopsy instead of full pelvic lymph node dissection to determine the spread... Continue Reading

January Is National Cervical Cancer Awareness Month (March 8, 2009)

Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer (March 8, 2009)

Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer Robotically-assisted hysterectomy (RAH) in patients with early-stage cervical cancer is at least as effective as traditional open radical hysterectomy (ORH) and produces fewer complications,... Continue Reading

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (March 8, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison... Continue Reading

Updates in the Management of Gynecologic Cancers (May 27, 2008)

More Stage I Cervical Cancer

Stage I Node Negative Breast Cancer

Lymphoseek Approved for Detecting Lymph Nodes in Breast Cancer and Melanoma (April 10, 2013)

Radiation for Breast Cancer Increases Risk of Heart Disease and Heart Attack (March 27, 2013)

Prognosis of Triple-Negative Breast Cancer Varies By Age (March 19, 2013)

The prognosis of triple-negative breast cancer (TNBC) tends to be better among older women than among younger women, even though older women are less likely to receive aggressive treatment. These results were published in Breast Cancer Research and Treatment. Previous... Continue Reading

Long-Term Adjuvant Tamoxifen Extends Survival and Reduces Risk of Late Recurrence (December 10, 2012)

Women with estrogen receptor-positive (ER-positive) breast cancer who take adjuvant tamoxifen for 10 years experience greater protection from late recurrence and death from breast cancer compared to those who take tamoxifen for the standard five years,... Continue Reading

Breast Brachytherapy May Result in More Complications (October 31, 2012)

More Stage I Node Negative Breast Cancer

Stage I Ovarian Cancer

Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)

Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)

Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (November 20, 2012)

Gene Helps Predict Response to Chemotherapy in Ovarian Cancer (September 28, 2012)

BRCA Genes May Influence Ovarian Cancer Outcomes (October 24, 2011)

Among women with ovarian cancer, those who have a BRCA2 gene mutation may have a better response to chemotherapy and longer survival than those who do not have a BRCA gene mutation. These results were published in the Journal of the American Medical Association. Inherited... Continue Reading

More Stage I Ovarian Cancer

Stage I-II Testicular Cancer

Marijuana May Increase Risk of Testicular Cancer (September 21, 2012)

Low-Dose CT Scans Effective for Surveillance of Early Testicular Cancer (June 15, 2011)

Low-dose computed tomography (CT) scans provide a reliable method for surveillance and reduce radiation exposure by 40-60% among patients with Stage I testicular cancer. These results were recently presented at the 2011 annual meeting of the American... Continue Reading

New Genes Linked to Testicular Cancer (June 28, 2010)

Scientists have discovered three new genes associated with testicular cancer, according to the results of a study published in Nature Genetics.[1] Testicular cancer is the most common type of cancer in men ages 15 to 45. The incidence of testicular cancer... Continue Reading

Men with Infertility May Have Increased Risk of Testicular Cancer (March 8, 2009)

Men with Infertility May Have Increased Risk of Testicular Cancer Men with infertility are three times more likely to develop testicular cancer compared with fertile men, according to the results of a study published in the Archives of Internal Medicine.[1] The... Continue Reading

Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer (March 8, 2009)

Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer Among men with Stage I seminoma (a type of testicular cancer), post-surgery treatment with a single dose of the chemotherapy drug carboplatin is as effective as two to... Continue Reading

More Stage I-II Testicular Cancer

Stage I/Smoldering Myeloma Multiple Myeloma

Carfilzomib Promising in Newly Diagnosed Multiple Myeloma (March 13, 2012)

The investigational drug carfilzomib, in combination with Revlimid® (lenalidomide) and low-dose dexamethasone, produced high response rates in patients with newly diagnosed myeloma. The results of this Phase I/II clinical trial were presented at the... Continue Reading

Continuous Revlimid May Improve Outcomes in Newly Diagnosed Multiple Myeloma (December 15, 2010)

Among older patients with newly diagnosed multiple myeloma, treatment with Revlimid® (lenalidomide) in combination with melphalan and prednisone, followed by Revlimid maintenance therapy (MPR-R) may result in better progression-free survival than two... Continue Reading

Revlimid Maintenance Slows Myeloma Progression After Stem Cell Transplant (December 14, 2010)

Maintenance therapy with Revlimid® (lenalidomide) reduced the risk of myeloma progression or death by 60% among patients who had undergone an autologous stem cell transplant. These updated results from a Phase III clinical trial were presented at the... Continue Reading

Improved Survival with Zometa in Multiple Myeloma (December 14, 2010)

It appears that treatment of patients with newly diagnosed multiple myeloma with Zometa® (zoledronic acid) may improve overall survival and progression-free survival. These findings were recently reported in The Lancet. Multiple myeloma is a cancer of... Continue Reading

Combination of Velcade and Revlimid Promising Against Newly Diagnosed Multiple Myeloma (October 29, 2010)

Among patients with symptomatic newly diagnosed multiple myeloma, treatment with a combination of Revlimid® (lenalidomide), Velcade® (bortezomib), and dexamethasone produced a partial response or better in 100% of patients. The results of this Phase... Continue Reading

More Stage I/Smoldering Myeloma Multiple Myeloma

Stage II-IV Ovarian Cancer

Delaying Chemotherapy Increases Mortality in Ovarian Cancer (April 12, 2013)

Ovarian Cancer Rates Declining in Breast Cancer Survivors (February 7, 2013)

Diabetes Drug May Help Prevent or Treat Ovarian Cancer (December 3, 2012)

Treatment at High-Volume Hospitals Leads to Lower Mortality Rates for Ovarian Patients (November 20, 2012)

Gene Helps Predict Response to Chemotherapy in Ovarian Cancer (September 28, 2012)

More Stage II-IV Ovarian Cancer

Stage III Bladder Cancer

Robotic Bladder Cancer Surgery Safe and Effective (January 24, 2013)

Study Explores New Approach to Boosting the Immune System after Cancer Treatment (August 24, 2011)

Researchers are seeking participants for a Phase II clinical trial that will explore whether an investigational treatment can help the immune system recover after cancer treatment. Cancer treatments such as chemotherapy and radiation therapy often deplete... Continue Reading

More Stage III Bladder Cancer

Stage III Melanoma

Adjuvant Radiotherapy for the Management of High-Risk Malignant Melanoma (September 24, 2012)

New Targeted Therapies Show Promise in Advanced Melanoma (June 18, 2012)

Two new targeted therapies—trametinib and dabrafenib—show promise in the treatment of advanced melanoma, either improving survival or delaying disease progression, according to the results of two studies presented at the 2012 annual meeting of the... Continue Reading

Melanoma Drug Accelerates Secondary Skin Cancers In Some Patients (January 23, 2012)

Zelboraf® (vemurafenib) improves outcomes among patients with advanced melanoma that harbors a BRAF gene mutation, but also accelerates the development of squamous cell carcinoma in some patients. A study that explores the reasons for these secondary... Continue Reading

Zelboraf (Vemurafenib) Approved for Melanoma (August 22, 2011)

The targeted therapy Zelboraf™ (vemurafenib) has been approved by the US Food and Drug Administration (FDA) for the treatment of melanomas that carry a common mutation in the BRAF gene. Of the more than one million new diagnoses of skin cancer each... Continue Reading

Sentinel Node Biopsy Safe and Effective for Melanomas on Head and Neck (August 10, 2011)

Although the head and neck region is complex and delicate, sentinel lymph node biopsy for melanomas of the head or neck appears to be safe and effective. These results were published in Cancer. Skin cancer is the most commonly diagnosed cancer in the... Continue Reading

More Stage III Melanoma

Stage III Testicular Cancer

Marijuana May Increase Risk of Testicular Cancer (September 21, 2012)

New Genes Linked to Testicular Cancer (June 28, 2010)

More Stage III Testicular Cancer

Stage IV (D)/Relapsed Colon Cancer

Combo Treatment Effective in Elderly Patients with Metastatic Colorectal Cancer (March 6, 2013)

Neulasta Significantly Reduces Febrile Neutropenia Among Colorectal Cancer Patients Receiving Chemotherapy Plus Avasatin (February 25, 2013)

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)

Zaltrap Improves Survival in Metastatic Colorectal Cancer (October 16, 2012)

The addition of Zaltrap® (ziv-aflibercept) to the FOLFIRI chemotherapy regimen improved overall survival in patients with metastatic colorectal cancer who were previously treated with Eloxatin® (oxaliplatin), according to the results of a phase III... Continue Reading

Stivarga Approved for Metastatic Colorectal Cancer (October 3, 2012)

The U.S. Food and Drug Administration (FDA) has approved Stivarga® (regorafenib) for the treatment of patients with metastatic colorectal cancer that has progressed following previous treatment. Colorectal cancer remains the second leading cause of cancer-related... Continue Reading

More Stage IV (D)/Relapsed Colon Cancer

Stage IV Anal Cancer

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

No Benefit with Addition of Platinol® to Treatment for Anal Cancer (May 1, 2008)

No Benefit with Addition of Platinol® to Treatment for Anal Cancer Addition of the drug Platinol® (cisplatin) to 5-FU (5-flourouracil), mitomycin, and radiation may not improve outcomes for patients with anal cancer. These findings were recently published... Continue Reading

More Stage IV Anal Cancer

Stage IV Liver Cancer

Nexavar Superior to Sutent in Liver Cancer (June 23, 2011)

Nexavar® (sorafenib) provides superior overall survival to Sutent® (sunitinib) in the treatment of hepatocellular (liver) cancer. These results were presented at the 2011 annual American Society of Clinical Oncology (ASCO) meeting. Hepatocellular carcinoma... Continue Reading

Cabozantinib Shows Promise against Bone Metastases (May 31, 2011)

FDA Grants Orphan Drug Status to Investigational Liver Cancer Drug (May 2, 2011)

PV-10—an investigational liver cancer drug—has been designated an orphan drug by the US Food and Drug Administration (FDA). The orphan drug designation is intended to encourage the development of drugs for rare diseases by providing incentives for... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Combination Chemotherapy Improves Survival with Biliary Tract Cancer (May 17, 2010)

According to the results of a Phase III clinical trial, treatment of locally advanced or metastatic biliary tract cancer with a combination of Gemzar® (gemcitabine) and cisplatin results in better survival and a lower risk of cancer progression than... Continue Reading

More Stage IV Liver Cancer

Stage IV Melanoma

Combined Targeted Therapy Safe and Effective in Metastatic Melanoma (October 24, 2012)

New Targeted Therapies Show Promise in Advanced Melanoma (June 18, 2012)

PD-1 Targeted Immune Therapy Shows Promising Activity (June 11, 2012)

Zelboraf Improves Melanoma Survival (March 16, 2012)

Melanoma Drug Accelerates Secondary Skin Cancers In Some Patients (January 23, 2012)

More Stage IV Melanoma

Stage IV Pancreatic Cancer

Abraxane Improves Survival in Pancreatic Cancer (February 13, 2013)

Sutent Approved for Pancreatic Neuroendocrine Tumors (PNET) (June 2, 2011)

The US Food and Drug Administration has approved the targeted drug Sutent® (sunitinib) for the treatment pancreatic neuroendocrine tumors (PNET). Pancreatic neuroendocrine tumors are an uncommon type of cancer that develops in the hormone-producing cells... Continue Reading

Novel Chemotherapy Regimen Outperforms Gemzar for Pancreatic Cancer (May 18, 2011)

For people with metastatic pancreatic cancer, the chemotherapy combination known as FOLFIRINOX results in better overall survival than standard treatment with Gemzar® (gemcitabine), but also increases side effects. These results were published in the... Continue Reading

New Approach to Immune Therapy Shows Promise against Pancreatic Cancer (April 1, 2011)

An investigational type of immune therapy that attacks the tissue around a tumor has shown promise in a small study of patients with advanced pancreatic cancer. These results were published in the journal Science. Immune therapies stimulate the body’s... Continue Reading

Addition of Axitinib Fails to Improve Pancreatic Cancer Outcomes (February 23, 2011)

Among patients with advanced pancreatic cancer, treatment with a combination of Gemzar® (gemcitabine) and the investigational drug axitinib did not result in better outcomes than treatment with Gemzar alone. The results of this Phase III clinical trial... Continue Reading

More Stage IV Pancreatic Cancer

Stage IV Rectal Cancer

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)

Zaltrap Approved for Metastatic Colorectal Cancer (August 15, 2012)

Continued Avastin Extends Survival After First Progression in Advanced Colorectal Cancer (June 14, 2012)

Combined second-line treatment with Avastin® (bevacizumab) and standard chemotherapy extends survival in patients with advanced colorectal cancer who have received first-line combined Avastin treatment, according to the results of a large phase III study... Continue Reading

Regorafenib Shows Promise Against Metastatic Colorectal Cancer (January 19, 2012)

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

More Stage IV Rectal Cancer

Stage IV Uterine Cancer

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Risk Factors Identified for Uterine Sarcoma Survival (March 8, 2009)

Risk Factors Identified for Uterine Sarcoma Survival Survival for patients diagnosed with uterine leiomyosarcomas may be influenced by several factors. These findings were recently published in the journal Cancer. The uterus is located in the abdomen... Continue Reading

Updates in the Management of Gynecologic Cancers (May 27, 2008)

More Stage IV Uterine Cancer

Stage IV/Metastatic Bladder Cancer

Robotic Bladder Cancer Surgery Safe and Effective (January 24, 2013)

Adding Chemotherapy to Radiation Reduces Bladder Cancer Recurrence (April 30, 2012)

Chemotherapy plus radiation reduces the risk of recurrence in muscle-invasive bladder cancer patients by nearly 50% compared to radiation alone, according to the results of a study published in the New England Journal of Medicine.[1] Bladder cancer is... Continue Reading

Liposomal Cisplatin Safe for Patients with Renal Insufficiency (June 14, 2011)

Liposomal cisplatin (Nanoplatin®), a chemotherapy drug still in clinical trials, does not cause damage to the kidneys and appears to provide at least equal anti-cancer effects as cisplatin (Platinol®) among cancer patients with renal insufficiency.... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

New Bladder-preserving Therapy Promising in Bladder Cancer (November 9, 2010)

A new bladder-preserving approach to treatment of locally invasive bladder cancer appears promising, both for patients for whom radical cystectomy is indicated and for those previously ineligible for curative treatment. These findings were recently published... Continue Reading

More Stage IV/Metastatic Bladder Cancer

Stage IV/Recurrent Esophageal Cancer

Second-Line Docetaxel Improves Survival in Esophageal and Gastric Cancer (April 3, 2013)

Surgery Improves Survival in Esophageal Cancer (February 21, 2013)

Iressa Improves Progression-Free Survival in Metastatic Esophageal Cancer (October 5, 2012)

Treatment with Iressa® (gefitinib) slowed disease progression and improved quality of life in patients with metastatic esophageal cancer, according to the results of a phase III trial presented at the ESMO 2012 Congress of the European Society for Medical... Continue Reading

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Some Patients with Advanced Cancer Continue Screening (October 22, 2010)

More Stage IV/Recurrent Esophageal Cancer

Stages 0-I Bladder Cancer

Robotic Bladder Cancer Surgery Safe and Effective (January 24, 2013)

Study Compares Two Types of BCG for Bladder Cancer (April 10, 2012)

For non-muscle-invasive bladder cancer, use of theConnaughtstrain of bacillus Calmette-Guérin (BCG) may be more effective at preventing recurrences than the Tice strain of BCG. These results—from a Phase III clinical trial—were presented at the 2012... Continue Reading

More Stages 0-I Bladder Cancer

Stages I-II Anal Cancer

Intensity-Modulated Radiation Therapy Reduces Side Effects for Patients with Anal Cancer (January 31, 2011)

Treatment of anal cancer with chemotherapy and intensity-modulated radiation therapy (IMRT) may be as effective as treatment with conventional radiation and chemotherapy but with fewer side effects. These findings were presented at the eighth annual Gastrointestinal... Continue Reading

No Benefit with Addition of Platinol® to Treatment for Anal Cancer (May 1, 2008)

More Stages I-II Anal Cancer

Stages I-II Gastric Cancer

Adjuvant Radiochemotherapy Demonstrates Benefit in Gastric Cancer (September 25, 2012)

XELOX May Improve Survival in Gastric Cancer (June 24, 2011)

The chemotherapy regimen referred to as XELOX may improve overall survival compared with observation alone in stages II and III gastric (stomach) cancer; however, data are still immature and longer follow-up is necessary. These results were presented... Continue Reading

Genetic Variant Associated with Poor Outcome for Gastric Cancer (May 24, 2010)

Patients with gastric cancer who have a certain type of inherited variation in the CD44 gene experience a significantly shorter time to disease recurrence (2.1 years) compared with patients without the genetic variation (seven years), according to the... Continue Reading

Adjuvant Chemotherapy Clinical Trial Data from Last 30 Years Evaluated to Determine Benefit in Gastric Cancer (May 15, 2010)

A moderate but statistically significant survival benefit was reported with the addition of chemotherapy to surgery in patients with resectable gastric cancer (gastric cancer that can be surgically removed). These findings were recently published in... Continue Reading

In Gastric Cancer Antibiotics Following Surgery Reduce Risk of Second Gastric Cancer (March 8, 2009)

In Gastric Cancer Antibiotics Following Surgery Reduce Risk of Second Gastric Cancer Among patients diagnosed with gastric (stomach) cancer, a combination of antibiotics against the bacterium Helicobacter pylori (H. pylori) significantly reduces the risk... Continue Reading

More Stages I-II Gastric Cancer

Stages I-II Melanoma

Lymphoseek Approved for Detecting Lymph Nodes in Breast Cancer and Melanoma (April 10, 2013)

Women More Likely to Survive Melanoma Than Men (May 16, 2012)

Women are 30 percent more likely to survive melanoma than men, according to the results of a study published in the Journal of Clinical Oncology.[1] Melanoma is a deadly type of skin cancer that arises from melanocytes, which are cells located in the... Continue Reading

Sentinel Node Biopsy Safe and Effective for Melanomas on Head and Neck (August 10, 2011)

Wealthy Women at Higher Risk of Melanoma (April 6, 2011)

It appears that wealthier White women may be at a higher risk of melanoma than less affluent women. These findings were recently published in the Archives of Dermatology. Melanoma is the most deadly type of skin cancer. Each year in the United States,... Continue Reading

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases. These findings were recently... Continue Reading

More Stages I-II Melanoma

Stages I-III Esophageal Cancer

Surgery Improves Survival in Esophageal Cancer (February 21, 2013)

Surgeon Volume Influences Outcomes in Esophageal Cancer (February 6, 2013)

Preoperative Chemoradiotherapy Improves Survival in Esophageal Cancer (September 10, 2012)

Preoperative chemoradiotherapy doubled median overall survival among patients with esophageal or esophagogastric junction cancer compared to surgery alone, according to the results of a phase 3 study published in the New England Journal of Medicine. The... Continue Reading

Minimally Invasive Surgery a Viable Option for Esophageal Cancer (June 26, 2012)

Minimally invasive surgery may provide short-term benefits in resectable esophageal cancer, reducing the risk of pulmonary infection and improving quality of life, according to the results of a study published in The Lancet. The esophagus is a muscular... Continue Reading

ERCC1 Levels Strongly Associated with Survival in Esophageal Cancer (June 13, 2011)

Levels of expression of a specific gene (ERCC1 gene) are strongly associated with survival outcomes among patients with operable esophageal cancer undergoing platinum-based chemotherapy. Results such as these may help guide personalized treatment options... Continue Reading

More Stages I-III Esophageal Cancer

Stages I-III Liver Cancer

Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (November 26, 2012)

Nexavar Superior to Sutent in Liver Cancer (June 23, 2011)

Combination Chemotherapy Improves Survival with Biliary Tract Cancer (May 17, 2010)

Sutent® Not Effective for Advanced Liver Cancer (July 10, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Liver Cancer (March 8, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Liver Cancer Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies... Continue Reading

More Stages I-III Liver Cancer

Stages I-III Pancreatic Cancer

Sutent Approved for Pancreatic Neuroendocrine Tumors (PNET) (June 2, 2011)

New Approach to Immune Therapy Shows Promise against Pancreatic Cancer (April 1, 2011)

Addition of Axitinib Fails to Improve Pancreatic Cancer Outcomes (February 23, 2011)

Gemzar Versus 5-FU for Adjuvant Treatment of Pancreatic Cancer (September 21, 2010)

A large randomized study demonstrated no significant improvement in survival with Gemzar® (gemcitabine) versus 5-fluorouracil (5-FU) for the adjuvant (post-surgery) treatment of pancreatic cancer. These findings were recently published in the Journal... Continue Reading

November Is National Pancreatic Cancer Awareness Month (November 5, 2009)

More Stages I-III Pancreatic Cancer

Stages I-III Rectal Cancer

Aspirin May Prolong Life in PIK3CA-Mutated Colorectal Cancers (November 6, 2012)

Adjuvant Therapy May Offer Survival Benefit in Older Patients with Colorectal Cancer (September 11, 2012)

Rectal Cancer Patients May Benefit from Higher Dose of Preoperative Radiation (October 12, 2011)

Among rectal cancer patients treated with chemotherapy and radiation therapy prior to surgery, providing a higher dose of radiation therapy (50 Gy rather than 45 Gy) may reduce the risk of cancer recurrence. These results were presented at the 53rd Annual... Continue Reading

African Americans Most Willing to Exhaust Resources for Life-Extending Care (May 5, 2011)

African Americans who are diagnosed with lung or colorectal cancer may be more willing than Whites to expend all personal financial resources in order to extend their lives. Other minority groups also appear more likely than Whites to use personal resources.... Continue Reading

Pathological Complete Response Predicts Better Outcomes in Locally Advanced Rectal Cancer Patients (August 25, 2010)

Among patients with locally advanced rectal cancer, a complete disappearance of detectable cancer (pathological complete response) after preoperative chemoradiation therapy is linked with better long-term outcomes. These findings were recently published... Continue Reading

More Stages I-III Rectal Cancer

Stages I-III Uterine Cancer

Study Supports Laparoscopy for Uterine Cancer (March 5, 2012)

Compared with traditional open surgery (laparotomy), laparoscopic surgery for uterine cancer results in quicker recovery, slightly higher recurrence rates, and similar overall survival. These results were published in the Journal of Clinical Oncology. Each... Continue Reading

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Laparoscopic Hysterectomy for Endometrial Cancer Associated with Better Quality of Life (August 3, 2010)

Laparoscopic hysterectomy for endometrial cancer that is confined to the uterus is associated with less pain, shorter hospital stays, faster recovery, and better quality of life when compared with total abdominal hysterectomy, according to the results... Continue Reading

Vaginal Brachytherapy Effective for Endometrial Cancer (March 17, 2010)

Among women who have undergone surgery for high-intermediate risk endometrial cancer, vaginal brachytherapy is as effective as pelvic external beam radiotherapy in the prevention of vaginal recurrence and produces fewer side effects. These results... Continue Reading

Adjuvant Radiation Therapy May Improve Survival in Stage III Uterine Cancer (October 22, 2009)

Among women with node-positive Stage III uterine cancer, use of adjuvant (post-surgery) radiation therapy appears to improve survival. These results were published in Gynecologic Oncology. Stage III uterine cancer extends outside the uterus but remains... Continue Reading

More Stages I-III Uterine Cancer

Stages I-IIIA Lung Cancer - Non-Small Cell

Stereotactic Body Radiation Improves Lung Cancer Survival (November 9, 2012)

Genetic Study Identifies New Targets for Treating Squamous Cell Lung Cancer (September 19, 2012)

Overall Health, Not Just Age, is an Important Factor in Treatment of Non-Small Cell Lung Cancer (May 14, 2012)

Younger patients with non-small cell lung cancer (NSCLC) are more likely to receive treatment than older patients, regardless of overall health and prognosis, according to the results of a study published in the Journal of Clinical Oncology. Lung cancer... Continue Reading

Some Lung Cancer Patients Receive Potentially Unhelpful Treatment (March 2, 2012)

Among older patients who undergo surgery for locally advanced, non-small-cell lung cancer, many receive postoperative radiation therapy. The radiation therapy, however, may not improve treatment outcomes. These results were published in Cancer. Lung cancer... Continue Reading

Higher Radiation Dose Does Not Benefit Lung Cancer Patients (October 13, 2011)

Among patients with Stage III non-small cell lung cancer, treatment with a higher dose of radiation therapy does not result in better overall survival than a standard dose of radiation therapy. These results were presented at the 53rd Annual Meeting of... Continue Reading

More Stages I-IIIA Lung Cancer - Non-Small Cell

Stages II-III Bladder Cancer

Robotic Bladder Cancer Surgery Safe and Effective (January 24, 2013)

Adding Chemotherapy to Radiation Reduces Bladder Cancer Recurrence (April 30, 2012)

Study Explores New Approach to Boosting the Immune System after Cancer Treatment (August 24, 2011)

Liposomal Cisplatin Safe for Patients with Renal Insufficiency (June 14, 2011)

New Bladder-preserving Therapy Promising in Bladder Cancer (November 9, 2010)

More Stages II-III Bladder Cancer

Stages II-III Breast Cancer

Lymphoseek Approved for Detecting Lymph Nodes in Breast Cancer and Melanoma (April 10, 2013)

Oncotype DX Recurrence Score Can Predict Loco-Regional Recurrence in Node-positive, ER-Positive Breast Cancer (April 9, 2013)

The Oncotype DX® Recurrence Score® result is a robust predictor of loco-regional recurrence in node-positive, estrogen receptor (ER)-positive patients treated with adjuvant hormonal therapy and chemotherapy, according to the results of a study presented... Continue Reading

Radiation for Breast Cancer Increases Risk of Heart Disease and Heart Attack (March 27, 2013)

Prognosis of Triple-Negative Breast Cancer Varies By Age (March 19, 2013)

Copper Depletion May Reduce Spread of Triple-Negative Breast Cancer (March 4, 2013)

More Stages II-III Breast Cancer

Stages II-III Multiple Myeloma

Zevalin Effective in Relapsed/Refractory Follicular Lymphoma (January 11, 2013)

Pomalidomide Improves Survival in Refractory Multiple Myeloma (January 8, 2013)

MLN9708 “Oral Velcade” Shows Promise in Multiple Myeloma (January 3, 2013)

Velcade Effective for Induction and Maintenance Treatment of Multiple Myeloma (September 7, 2012)

Velcade® (bortezomib) during induction and maintenance treatment improves survival in newly diagnosed stage II or III multiple myeloma, according to the results of a study published in the Journal of Clinical Oncology. Multiple myeloma is a cancer of... Continue Reading

Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (May 18, 2012)

Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies published in the New England Journal of Medicine. Multiple... Continue Reading

More Stages II-III Multiple Myeloma

Stages II-IVA Cervical Cancer

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer (June 8, 2009)

Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer The combination of Gemzar® (gemcitabine), Platinol® (cisplatin), and concurrent radiation significantly improves survival over single-agent Platinol and radiation... Continue Reading

January Is National Cervical Cancer Awareness Month (March 8, 2009)

Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer (March 8, 2009)

Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (March 8, 2009)

More Stages II-IVA Cervical Cancer

Stages III-IV Gastric Cancer

Second-Line Docetaxel Improves Survival in Esophageal and Gastric Cancer (April 3, 2013)

Adjuvant Radiochemotherapy Demonstrates Benefit in Gastric Cancer (September 25, 2012)

XELOX May Improve Survival in Gastric Cancer (June 24, 2011)

Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)

Herceptin® Approved for HER2-positive Metastatic Stomach Cancer (November 2, 2010)

More Stages III-IV Gastric Cancer

Stages IIIB-IV Lung Cancer - Non-Small Cell

Xgeva Improves Survival Over Zometa in Advanced Lung Cancer (November 28, 2012)

Xalkori Superior to Standard Chemotherapy in ALK-Positive Lung Cancer (October 4, 2012)

Genetic Study Identifies New Targets for Treating Squamous Cell Lung Cancer (September 19, 2012)

Managing Locally Advanced NSCLC in the Elderly (September 5, 2012)

For some elderly patients with locally advanced non-small cell lung cancer (NSCLC), combination chemoradiotherapy provides a clinically significant benefit over radiotherapy alone, according to the results of a study published in The Lancet Oncology.[1] Lung... Continue Reading

Two Studies Show Promise in Second-Line Treatments for NSCLC (August 14, 2012)

More Stages IIIB-IV Lung Cancer - Non-Small Cell

Stem Cell Transplant

Zevalin Plus BEAM Chemotherapy Superior to BEAM Alone in Aggressive Lymphoma (March 22, 2013)

Antiretroviral Drug May Prevent Graft-Versus-Host Disease (August 6, 2012)

Mini-Transplants Continue to Show Promise for Older Patients with AML (November 10, 2011)

Less toxic cancer treatment followed by an allogeneic stem cell transplant is showing promise for older patients with advanced blood and bone marrow cancers such as acute myeloid leukemia (AML). These results were published in the Journal of the American... Continue Reading

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

Complementary Therapy for Children Undergoing Stem Cell Transplant (July 19, 2010)

More Stem Cell Transplant

Supportive

Sorry, there are no articles available for this cancer stage.

More Supportive

Supportive Care

Neulasta Significantly Reduces Febrile Neutropenia Among Colorectal Cancer Patients Receiving Chemotherapy Plus Avasatin (February 25, 2013)

Exercise Reduces Cancer-Related Fatigue (November 30, 2012)

Naproxen May Relieve Bone Pain Associated with Neulasta (August 2, 2012)

Nplate Produces Rapid Response in Adults with ITP (December 20, 2011)

Flaxseed Not Effective Against Hot Flashes (June 7, 2011)

Flaxseed does not reduce hot flashes among postmenopausal women. These results were presented at the 2011 annual meeting of the American Society of Clinical Oncology. Menopause—when menstrual cycles end and ovarian hormone production drops dramatically—produces... Continue Reading

More Supportive Care

Supportive Care Breast Cancer

Increase in Number of Women Undergoing Reconstruction Immediately after Mastectomy (January 22, 2013)

Some Evidence of Mild “Chemo Brain” in Breast Cancer Survivors (September 14, 2012)

Flaxseed Not Effective Against Hot Flashes (June 7, 2011)

Predicting Nerve Damage from Paclitaxel (June 6, 2011)

The chemotherapy drug paclitaxel can cause nerve damage in some patients. According to a study that will be presented at the 2011 annual meeting of the American Society of Clinical Oncology, specific genetic markers may eventually allow doctors to know... Continue Reading

Weight Lifting May Not Increase Lymphedema Risk Among Breast Cancer Survivors (January 7, 2011)

It may be safe for breast cancer survivors to lift weights, including upper-body exercises, without increasing risk for lymphedema. These results were reported in the Journal of the American Medical Association. Lymphedema refers to swelling of the arm... Continue Reading

More Supportive Care Breast Cancer

Sorry, there are no articles available for this cancer stage.

More T

T-Cell Non-Hodgkin's Lymphoma

Targeted Agent Xalkori May Benefit Children with Anaplastic Lymphoma (May 23, 2012)

Lymphoma During Pregnancy Can Have Good Outcomes (March 14, 2012)

Many Patients with “Chemo Brain” Recover within Five Years (May 23, 2011)

Folotyn Benefits Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (February 3, 2011)

In the Phase II PROPEL study, 29% of patients with relapsed or refractory peripheral T-cell lymphoma (a type of non-Hodgkin’s lymphoma) experienced a complete or partial disappearance of detectable cancer following treatment with Folotyn® (pralatrexate).... Continue Reading

Istodax Active against Refractory Cutaneous T-cell Lymphoma (August 31, 2010)

Final results from a Phase II clinical trial provide additional evidence that Istodax® (romidepsin) is active against refractory cutaneous T-cell lymphoma. These results were published in the Journal of Clinical Oncology. Cutaneous T-cell lymphoma (CTCL)... Continue Reading

More T-Cell Non-Hodgkin's Lymphoma

Testicular Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Marijuana May Increase Risk of Testicular Cancer (September 21, 2012)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

More Testicular Cancer

Throat Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

Do Complementary Therapies Work? – Ask the expert about herbs, acupuncture, and other complementary therapies (November 4, 2011)

More Throat Cancer

Thyroid Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Selumetinib May Reverse Radioiodine Resistance in Advance Thyroid Cancer (March 28, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Targeted Drug Caprelsa Slows Thyroid Cancer (August 30, 2012)

Gene Expression Test Identifies Low-Risk Thyroid Nodules (June 28, 2012)

More Thyroid Cancer

Types of Cancer

Number of Cancer Survivors Expected to Reach 18 Million by 2022 (May 1, 2013)

Heart Healthy Lifestyle Can Reduce Cancer Risk (April 19, 2013)

Exercise Reduces Cancer-Related Fatigue (November 30, 2012)

Statins Linked to Lower Cancer Mortality (November 19, 2012)

Multivitamins May Cut Cancer Risk (October 25, 2012)

More Types of Cancer

Sorry, there are no articles available for this cancer stage.

More U

Uncategorized

Mediterranean Diet May Lower Breast Cancer Risk (August 16, 2010)

Postmenopausal women who consume a traditional Mediterranean diet may have a lower risk for breast cancer, according to a study published in the American Journal of Clinical Nutrition. A traditional Mediterranean diet—one that is rich in fish, olive... Continue Reading

More Uncategorized

Uterine Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Number of Cancer Survivors Will Grow to 18 Million by 2022 (June 25, 2012)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

More Uterine Cancer

Sorry, there are no articles available for this cancer stage.

More V

Vaginal Cancer

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

Cancer Deaths on the Decline (February 11, 2013)

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)